- Staat
- -
- Alter
- 37,0
- Geschlecht
- M
- Eingang
- 11.07.2023
- Impfdatum
- 26.11.2021
- Beginn
- 05.04.2023
- Tage bis Beginn
- 495,0
- Dosis
- 3
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Acute respiratory failure
Angiogram pulmonary normal
Blast cells present
Blood culture negative
Blood lactic acid increased
Blood potassium decreased
Body temperature increased
Brain natriuretic peptide increased
COVID-19 pneumonia
Computerised tomogram thorax abnormal
Cough
Dyspnoea
Echocardiogram normal
Ejection fraction
Glycosylated haemoglobin increased
Hypokalaemia
Hypovolaemia
Hypoxia
Symptomtext
Patient is a 39 y.o. male patient of, DO with history of non-insulin-dependent diabetes type 2, obesity, hypertension,, hyperlipidemia presented to Hospital with complaints of shortness of breath and hypoxia. Acute hypoxic respiratory failure Severe sepsis secondary to COVID-19 viral pneumonia Date of onset of symptoms: 30 days Symptoms present on admission: Cough, congestion, hypoxia. Found to have tachycardia, tachypnea, Tmax 101.5, elevated LA, and leukocytosis for severe sepsis Date of covid positive test: 4/5/2023 Vaccination status: vaccinated Imaging: CT with extensive bilateral patchy infiltrates Oxygen requirements on admission: 5 L nasal cannula Current oxygen requirements: 8 L nasal cannula Medical therapy: Steroids, Levaquin, Ceftriaxone Consultants following: N/A Anticipated special isolation end date: TBD Urinary Ags negative, Mycoplasma negative, blood cultures x2 NGTD, sputum culture pending, pro-cal 0.36 Bronchodilators, Mucinex, Tessalon Perles Wean O2 requirements as able Concern for acute myeloid leukemia Leukocytosis WBC 30.79 Peripheral smear reviewed by pathology- leukocytosis with predominance of monocytes including immature forms accompanied by blasts Discussed with Dr. (Oncology) who recommended transfer to Facility Accepted at Facility, awaiting bed assignment Sinus tachycardia Suspecting secondary to underlying infection and hypovolemia CTPA negative for PE Echo shows LVEF 58% Elevated BNP BNP 971 Low suspicion for CHF exacerbation Echo wnl Hypokalemia K 3.2 Replace with 40 mEq Type 2 NIDDM Hold home oral agents HbA1c 9.5 on 3/1/23 SSI with accu-checks Thrombocytopenia Suspecting secondary to underlying infection Plts 46 Transfuse if Hb <7 Disposition Estimated Discharge Date: 4/6/23 Discharge Location: Facility
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- 2,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 66,0
- Geschlecht
- M
- Eingang
- 01.02.2023
- Impfdatum
- 26.11.2021
- Beginn
- 30.12.2022
- Tage bis Beginn
- 399,0
- Dosis
- 2
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Acute kidney injury
Acute respiratory failure
Blood creatinine increased
Blood potassium increased
Blood pressure increased
Blood urea increased
COVID-19
Cardiac dysfunction
Cardiac failure acute
Cardiac stress test
Chest X-ray abnormal
Chronic kidney disease
Condition aggravated
Dehydration
Dyspnoea
Echocardiogram abnormal
Ejection fraction
Essential hypertension
Symptomtext
Clinical Summary A 67 y.o. male with a history of HFmrEF, CKD IV, Chronic Hyperkalemia, Cirrhosis, CAD, NIDDM2, COPD, OSA, Polysubstance Abuse. Recent admission 12/11-12/16/22 for acute decompensated heart failure and progressive CKD IV and hyperkalemia with relapse of polysubstance abuse. Presents with AKI on CKD, hyperkalemia, COVID. Acute respiratory failure, Improved. Covid-19 Virus Infection Start of symptoms and positive test 12/29/2022 SOB & fatigue on admission Vaccinated Oxygen requirements on admission: 3L Medical therapy: Decadron 6mg every day x10 days (12/30 -1/9); CKD precludes remdesivir Weaned to RA prior to discharge AKI on CKD IV Outpatient provider Dr. Ddx: likely ATN from COVID vs. acute viral illness, dehydration, multimodal BP meds S/p 24hr of biarb gtt without improvement Cr remains elevated, 3.5-3.7 baseline 1/7 Cr 3.52 eGFR 18, BUN 79 1/8 Cr 3.97 eGFR 16, BUN 82 Renal diet & daily RFP Nephrology followed Continued home bumex 2mg daily Hyperkalemia Highest 6.1 on admission S/p Lokelma 10 g TID x 2 days; currently on 10 g daily, continue Bowel regimen: Miralax, Lokelma Continued home bumex Potassium 5.2 at baseline Has f/u with Nephro scheduled Essential hypertension BP elevated to 170 systolic Cont coreg and Imdur, Bumex Cont home hydralazine at 50mg bid May need additional titration up to 100 TID as outpatient Heart Failure with Reduced EF CXR w/ pulmonary edema Stress (11/2022): normal myocard perf, EF 47% Echo (4/2022): EF +/-55%, grade I dysfx Continued home carvedilol and imdur Held bumex in setting of AKI, restarted prior to discharge
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- 10,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MN
- Alter
- 91,0
- Geschlecht
- F
- Eingang
- 15.09.2022
- Impfdatum
- 02.12.2021
- Beginn
- 09.09.2022
- Tage bis Beginn
- 281,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Acute respiratory failure
Asthenia
COVID-19
COVID-19 pneumonia
Cough
Fatigue
Hypoxia
Pneumonia
Pneumonia bacterial
Pyrexia
SARS-CoV-2 test positive
Sepsis
Symptomtext
Patient brought into the ED on 9/9 by EMS for weakness and fatigue. A week prior to this, she began to have a cough and tested positive for COVID on 9/8. When EMS arrived to the scene, the patient was hypoxic in the 70's and febrile, so was placed on oxygen. She was admitted 9/9-9/11. Discharge diagnoses include severe COVID-19, COVID pneumonia, bilateral lung bacterial pneumonia with sepsis, and acute hypoxemic respiratory failure. During admission, patient was able to be weaned off supplemental oxygen. Patient has received COVID vaccine and one booster. This meets criteria for vaccine breakthrough case review.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 33,0
- Geschlecht
- F
- Eingang
- 17.06.2022
- Impfdatum
- 19.11.2021
- Beginn
- 18.01.2022
- Tage bis Beginn
- 60,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Amniocentesis normal
Cytogenetic analysis normal
Exposure during pregnancy
Foetal death
Hydrops foetalis
Prenatal screening test
Ultrasound antenatal screen normal
Symptomtext
Received third booster on 11/19/21. Appx 3 weeks pregnant at the time. Developed non-immune fetal hydrops early in pregnancy. Ultimately with severe hydrops, leading to fetal loss at 17 weeks pregnancy.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Foetal death
- Hospital-Tage
- -
- Labordaten
- Completed extensive genetic testing, all negative via NIPT testing, Vistara, and amniocentesis. Normal anatomy US. Inconclusive etiology.
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- Prenatal vitamin
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 35,0
- Geschlecht
- F
- Eingang
- 19.05.2022
- Impfdatum
- 18.11.2021
- Beginn
- 07.01.2022
- Tage bis Beginn
- 50,0
- Dosis
- 3
- Route/Site
- SYR / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Amniotic fluid volume decreased
Anticoagulant therapy
Breast feeding
Chest pain
Computerised tomogram thorax abnormal
Cough
Delivery
Exposure during pregnancy
Induced labour
Pulmonary embolism
Symptomtext
My pregnancy up until that point was normal with no complications. I had to be induced on 1/6/2022 I had low fluid so then I went into labor and delivered my daughter and immediately started coughing and had chest pain. Everyone thought it was my asthma or I had Covid. They discharged me on the 9th and I ended up going to the ER on the 10th. At the ER they did a CT scan and found a pulmonary embolism in my right lower lung. I was admitted into the hospital and discharged on the 12th of January and placed on blood thinners, which I'm still on. Once I'm done breast feeding they will do a follow-up CT scan to confirm the blot clot is gone and there are no others.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pulmonary embolism
- Hospital-Tage
- 2,0
- Labordaten
- CT scan and found a pulmonary embolism in my right lower lung.
- Aktuelle Erkrankungen
- No
- Vorgeschichte
- Asthma; migraines
- Andere Medikamente
- Prenatal vitamin
- Allergien
- No
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 81,0
- Geschlecht
- F
- Eingang
- 03.01.2022
- Impfdatum
- 05.11.2021
- Beginn
- 02.12.2021
- Tage bis Beginn
- 27,0
- Dosis
- 3
- Route/Site
- IM / AR
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Blood creatinine normal
Blood potassium decreased
Blood sodium increased
Blood urea increased
Death
General physical health deterioration
Haemoglobin normal
Mean cell volume normal
White blood cell count normal
Symptomtext
AFTER PT RECEIVED INITIAL DOSES OF VACCINE IN AUG 2021 STARTED HAVING INCREASED NEUROLOGICAL ISSUES, DECREASED MOBILITY TWITCHING/ JERKY MOVEMENT W/ FREQ FALLS. AFTER RECEIVING HER BOOSTER 11/05/2021 PT BEGAN TO DECLINE AFTER 3 WKS. PLACED ON COMFORT CARE 12/2/2021 AND EXPIRED 12/03/2021
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- 08/30/2021 NA 141, K+4.1, BUN 10, CR 0.6, WBC 5.1, HGB 12.2, MCV91.7 12/1/2021 NA 154, K+3.4, BUN 27 NO ADDITIONAL LABS TEST COMPLETED EITHER ON 08/30/2021 IN ED. AFTER 12/2/2021 PT/FAMILY DECIDED TO GO COMFORT CARE
- Aktuelle Erkrankungen
- PT RECEIVED HER FIRST DOSE OF PFIZER ON 4/16/2021, SECOND VACCINE ON 05/07/2021, BOOSTER 11/05/2021. AUGUST 2021 INCREASED NEUROLOGICAL ISSUES TWITCHING/ JERKY MOVEMENTS, FREQ FALLS
- Vorgeschichte
- AUGUST 2021 STARTED HAVING NEUROLOGICAL ISSUES, TWITCHING/ JERKING MOVEMENTS, DECREASE STRENGTH, UNABLE TO AMBULATE W/ WALKER AS PRIOR. AT HOME STARTED HAVING INCREASE CONF AND FALLS, PLACED IN SKILLED FACILITY THEN TRANSFERED TO US IN OCTOBER ACTIVELY WORKING W/ THEROPY, AFTER BOOSTER 3 WKS DECLINED QUICKLY AND EXPIRED 12/03/2021
- Andere Medikamente
- VITAMIN B12 1000 MCG PO DAILY, ACETAMINOPHEN 650 MG PO 2X'S DAILY, MIRTAZAPINE 7.5 MG PO @ HS, IBUPROFEN 600MG PO Q 6 HOURS AS NEEDED, 2-CAL MED PASS 120ML 3XS DAILY, ORDERED 12/2/21 O2 2-4L PER NC FOR COMFORT CONT, ROXANOL 20MG/ML 0.5ML/
- Allergien
- ACE INHIBITORS, BACTRIM, CIPRO, METFORMIN
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 44,0
- Geschlecht
- M
- Eingang
- 27.11.2021
- Impfdatum
- 05.11.2021
- Beginn
- 06.11.2021
- Tage bis Beginn
- 1,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Angiogram pulmonary abnormal
Anticoagulant therapy
Brain natriuretic peptide normal
Cardiac disorder
Cardiomegaly
Chest pain
Dyspnoea
Dyspnoea exertional
Fibrin D dimer
Osteopenia
Pleuritic pain
Pulmonary embolism
SARS-CoV-2 test
Troponin increased
Symptomtext
shortness of breath; dyspnea on exertion; pleuritic chest pain; Have large saddle pulmonary embolism with emboli extending into segmental and subsegmental branches of all lobes; This is a spontaneous report from a contactable physician. A 44-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 intramuscular, administered in Arm Left on 05Nov2021 (Lot Number: 33026BD) at age of 44 years old as DOSE 2, SINGLE for covid-19 immunisation. Medical history included hypertension, obstructive sleep apnea, chronic migraines, asthma, mitral valve prolapse and Covid. Concomitant medication(s) included eszopiclone; gabapentin; fluticasone propionate, salmeterol xinafoate (FLUTICASONE + SALMETEROL); naproxen; sumatriptan; hydrochlorothiazide; cholecalciferol; cyclobenzaprine; diclofenac; magnesium oxide; riboflavin; pantoprazole; lisinopril. The patient previously took the first dose of BNT162B2 (lot number: FH8020) Intramuscular in left arm on 15Oct2021 for COVID-19 immunization. The patient acutely developed shortness of breath and dyspnea on exertion within 24 hours following the 2nd dose of the vaccine which progressively worsened with subsequent development of pleuritic chest pain. Presented to the hospital approximately 6 days later and was found to have large saddle pulmonary embolism with emboli extending into segmental and subsegmental branches of all lobes. Patient was subsequently started on therapeutic anticoagulation with enoxaparin and plan for transition to rivaroxaban. Events started on 06Nov2021 and resulted in hospitalization. The patient was hospitalized for 3 days. Lab test included Nasal Swab/Cepheid RT-PCR on 11Nov2021 with Negative Covid test result. The outcome was recovering.; Sender's Comments: Based on current information available and considering drug-event temporal association a possible contributory role of the suspect BNT162B2 cannot be completely excluded for the reported events of Dyspnoea, Dyspnoea exertional, Pleuritic pain, Pulmonary embolism. The case will be reassessed further upon receipt of additional information. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pulmonary embolism
- Hospital-Tage
- 3,0
- Labordaten
- Test Date: 20211111; Test Name: Nasal Swab/Cepheid RT-PCR; Test Result: Negative
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Asthma; Chronic migraine; COVID-19; Hypertension; Mitral valve prolapse; Obstructive sleep apnea syndrome
- Andere Medikamente
- ESZOPICLONE; GABAPENTIN; FLUTICASONE + SALMETEROL; NAPROXEN; SUMATRIPTAN; HYDROCHLOROTHIAZIDE; CHOLECALCIFEROL; CYCLOBENZAPRINE; DICLOFENAC; MAGNESIUM OXIDE; RIBOFLAVIN; PANTOPRAZOLE; LISINOPRIL
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 44,0
- Geschlecht
- M
- Eingang
- 27.11.2021
- Impfdatum
- 05.11.2021
- Beginn
- 06.11.2021
- Tage bis Beginn
- 1,0
- Dosis
- 2
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Angiogram pulmonary abnormal
Anticoagulant therapy
Brain natriuretic peptide normal
Cardiac disorder
Cardiomegaly
Chest pain
Dyspnoea
Dyspnoea exertional
Fibrin D dimer
Osteopenia
Pleuritic pain
Pulmonary embolism
SARS-CoV-2 test
Troponin increased
Symptomtext
shortness of breath; dyspnea on exertion; pleuritic chest pain; Have large saddle pulmonary embolism with emboli extending into segmental and subsegmental branches of all lobes; This is a spontaneous report from a contactable physician. A 44-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 intramuscular, administered in Arm Left on 05Nov2021 (Lot Number: 33026BD) at age of 44 years old as DOSE 2, SINGLE for covid-19 immunisation. Medical history included hypertension, obstructive sleep apnea, chronic migraines, asthma, mitral valve prolapse and Covid. Concomitant medication(s) included eszopiclone; gabapentin; fluticasone propionate, salmeterol xinafoate (FLUTICASONE + SALMETEROL); naproxen; sumatriptan; hydrochlorothiazide; cholecalciferol; cyclobenzaprine; diclofenac; magnesium oxide; riboflavin; pantoprazole; lisinopril. The patient previously took the first dose of BNT162B2 (lot number: FH8020) Intramuscular in left arm on 15Oct2021 for COVID-19 immunization. The patient acutely developed shortness of breath and dyspnea on exertion within 24 hours following the 2nd dose of the vaccine which progressively worsened with subsequent development of pleuritic chest pain. Presented to the hospital approximately 6 days later and was found to have large saddle pulmonary embolism with emboli extending into segmental and subsegmental branches of all lobes. Patient was subsequently started on therapeutic anticoagulation with enoxaparin and plan for transition to rivaroxaban. Events started on 06Nov2021 and resulted in hospitalization. The patient was hospitalized for 3 days. Lab test included Nasal Swab/Cepheid RT-PCR on 11Nov2021 with Negative Covid test result. The outcome was recovering.; Sender's Comments: Based on current information available and considering drug-event temporal association a possible contributory role of the suspect BNT162B2 cannot be completely excluded for the reported events of Dyspnoea, Dyspnoea exertional, Pleuritic pain, Pulmonary embolism. The case will be reassessed further upon receipt of additional information. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pulmonary embolism
- Hospital-Tage
- 3,0
- Labordaten
- Test Date: 20211111; Test Name: Nasal Swab/Cepheid RT-PCR; Test Result: Negative
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Asthma; Chronic migraine; COVID-19; Hypertension; Mitral valve prolapse; Obstructive sleep apnea syndrome
- Andere Medikamente
- ESZOPICLONE; GABAPENTIN; FLUTICASONE + SALMETEROL; NAPROXEN; SUMATRIPTAN; HYDROCHLOROTHIAZIDE; CHOLECALCIFEROL; CYCLOBENZAPRINE; DICLOFENAC; MAGNESIUM OXIDE; RIBOFLAVIN; PANTOPRAZOLE; LISINOPRIL
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- AZ
- Alter
- 71,0
- Geschlecht
- F
- Eingang
- 12.03.2023
- Impfdatum
- 19.11.2021
- Beginn
- 09.12.2021
- Tage bis Beginn
- 20,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: ja
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: ja
Arteriogram coronary abnormal
Bundle branch block left
Cardiac failure congestive
Cardiac imaging procedure abnormal
Cardiomyopathy
Catheterisation cardiac normal
Echocardiogram abnormal
Ejection fraction decreased
Electrocardiogram abnormal
Laboratory test normal
Myocardial bridging
Myocarditis
Symptomtext
sudden onset cardiomyopathy with EF 22% congestive heart failure in patient iwht no cardiac disease. normal cath, MRI showed myocarditis
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Myocarditis
- Hospital-Tage
- -
- Labordaten
- cardiac angiogram normal except LAD bridging labs normal ekg LBBB cardiac mri myocarditis echo EF 22%
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- hypothyroid
- Andere Medikamente
- levothyroxine
- Allergien
- nkda no food allergies
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 59,0
- Geschlecht
- M
- Eingang
- 27.01.2023
- Impfdatum
- 07.11.2021
- Beginn
- 28.11.2021
- Tage bis Beginn
- 21,0
- Dosis
- 2
- Route/Site
- SYR / RA
Tod: unbekannt
Lebensbedrohlich: ja
Hospital: ja
Disable: ja
ER: ja
Erholt: nein
Arteriogram carotid
Blood test
Cerebellar stroke
Computerised tomogram head normal
Dizziness
Echocardiogram
Electrocardiogram
Laboratory test
Magnetic resonance imaging
Musculoskeletal disorder
Ultrasound Doppler
Vertigo
Vomiting
Symptomtext
BILATERAL CEREBELLAR STROKES I received the second shot of Pfizer MRNA on Nov 7, 2021. On Nov 29th, ,at the age of 59, I suffered the first of two strokes. Early that morning I woke up at approximately 1 am dizzy, throwing up and having some difficulty when moving my legs. My wife took me to a local emergency hospital. They did a CT scan of my head and said it was clear, no sign of a stroke. I was diagnosed with vertigo, given anti-nausea prescriptions and sent home that morning feeling ok. The following morning it happened again so we went back to the same emergency hospital and they wanted to transport me by ambulance (See continuation pg)
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cerebellar stroke
- Hospital-Tage
- 78,0
- Labordaten
- November 30-Dec 1, 2021- Head Ct's, MRI, numerous blood tests, CTA Neck, US Doplr ART Carotid Bilat, EKG,Echocardiogram, bubble study. Too many tests to list see medical records
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- Anastrozole, testosterone cypionate, (PRN: Zolipidem & Afrin)
- Allergien
- Sulfa, penicillins
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 72,0
- Geschlecht
- F
- Eingang
- 15.02.2022
- Impfdatum
- 10.11.2021
- Beginn
- 02.02.2022
- Tage bis Beginn
- 84,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Anticoagulant therapy
Asymptomatic COVID-19
Blood sodium decreased
COVID-19
Eye injury
Eye operation
Eye pain
Eye swelling
Facial bones fracture
Fall
Hyponatraemia
Intraocular pressure test normal
Orbital haematoma
SARS-CoV-2 test positive
Syncope
Symptomtext
Patient states she had a syncopal episode getting out of the shower 01/25/2022. Had a mild prodrome. Fell striking her right eye. Was seen at an outside facility where imaging showed zygomatic fractures. Ocular pressure stable. Also incidentally found COVID positive the same date. Asymptomatic. Is fully vaccinated. Has been following with Ophthalmology. As of this morning had increasing right eye swelling and pain so presented for cares. Imaging here showed retro-orbital hematoma. Warfarin reversed with Kcentra and 10 mg of vitamin K. Seen by Ophthalmology who performed Right lateral canthotomy/cantholysis. Eyedrops prescribed. Patient was also found to be hyponatremic at 123. She has run slightly hypo
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syncope
- Hospital-Tage
- 1,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 63,0
- Geschlecht
- M
- Eingang
- 19.01.2022
- Impfdatum
- 13.11.2021
- Beginn
- 14.11.2021
- Tage bis Beginn
- 1,0
- Dosis
- 3
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: ja
Hospital: ja
Disable: ja
ER: ja
Erholt: ja
Cardiac failure
Dyspnoea
Fatigue
Intensive care
Laboratory test
Loss of consciousness
Mechanical ventilation
Peripheral swelling
Pulmonary thrombosis
Seizure
Swelling
Symptomtext
After the booster shot, patient felt extremely tired, difficulty with breathing, shortness of breath, swollen legs and increasing waistline. He could not lie flat in bed at night when he slept. He had to sit-up all night in order to be able to breathe during sleeping hours. The situation lasted for a few weeks until he had a seizure and passed-out on Dec 27, 2021. He was sent to emergency room and diagnosed for heart failure due to clotting in his pulmonary arteries. He stayed in ICU for 6 days on a ventilator. He was released from hospital on Jan 12, 2022 after staying there for 16 days.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Intensive care
- Hospital-Tage
- 16,0
- Labordaten
- We don't have the lab results. Please contact the doctor's office for records.
- Aktuelle Erkrankungen
- High blood pressure
- Vorgeschichte
- High blood pressure
- Andere Medikamente
- Nifedipine ER, Metoprolol Tartrate
- Allergien
- Unknown
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 32,0
- Geschlecht
- M
- Eingang
- 16.12.2021
- Impfdatum
- 15.12.2021
- Beginn
- 16.12.2021
- Tage bis Beginn
- 1,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Loss of consciousness
Pain in extremity
Symptomtext
Arm has been sore and in pain. At approximately 1.30am (12 hours after receiving the booster shot) the patient went to the bathroom over night and lost consciousness. He passed out for approximately 30-45 seconds. He has no history of adverse reactions to vaccines or shots.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Loss of consciousness
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- Penicillin
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 25,0
- Geschlecht
- M
- Eingang
- 15.12.2021
- Impfdatum
- 10.12.2021
- Beginn
- 10.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
Amnesia
Concussion
Face injury
Syncope
Symptomtext
Syncope with injury to face, concussion with short term memory loss
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syncope
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Hyperhidrosis
- Andere Medikamente
- Glycopyrrolate
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 83,0
- Geschlecht
- M
- Eingang
- 02.12.2021
- Impfdatum
- 05.11.2021
- Beginn
- 11.11.2021
- Tage bis Beginn
- 6,0
- Dosis
- 1
- Route/Site
- IM / AR
Tod: unbekannt
Lebensbedrohlich: ja
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Arterial haemorrhage
Endoscopy
Endotracheal intubation
Gastrointestinal haemorrhage
Imaging procedure
Intensive care
Laboratory test
Transfusion
Vascular cauterisation
Mesenteric haemorrhage
Symptomtext
Mesenteric arterial gastrointestinal bleed severe; This is a spontaneous report from a contactable nurse. An 83-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), intramuscular, administration date 05Nov2021 10:00 (Lot number: 33026BD) at the age of 83 years as DOSE 1, SINGLE for COVID-19 immunisation, in nursing home/senior living facility. No other vaccine in four weeks. Relevant medical history included: "Chronic DM2" (unspecified if ongoing); "HTN" (unspecified if ongoing); "Gerd" (unspecified if ongoing); "Neuropathy" (unspecified if ongoing). No COVID prior vaccination. Concomitant medications included: ASPRIN; CYMBALTA; LISINOPRIL; TYLENOL; COREG; METFORMIN. The following information was reported: MESENTERIC HAEMORRHAGE (hospitalization, life threatening) with onset 11Nov2021 13:30, outcome "not recovered", described as "Mesenteric arterial gastrointestinal bleed severe". Clinical course: mesenteric arterial gastrointestinal bleed severe, requiring hospitalization w/ transfer to hospital w/higher level of care. ICU Intubated and received multiple units of blood, GI scope w/interventions, currently still hospitalized w/ no estimated discharge date. The patient was hospitalized for mesenteric haemorrhage (hospitalization duration: 7 days). The event "mesenteric arterial gastrointestinal bleed severe" was evaluated at the emergency room visit. Therapeutic measures were taken as a result of mesenteric haemorrhage and included treatment with multiple units of blood. No COVID tested post vaccination; Sender's Comments: Based on the available information in the case, the causal association between the event mesenteric haemorrhage and the suspect drug BNT162B2 cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Intensive care
- Hospital-Tage
- 7,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: GERD; Hypertension; Neuropathy; Type II diabetes mellitus
- Andere Medikamente
- ASPRIN; CYMBALTA; LISINOPRIL; TYLENOL; COREG; METFORMIN
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 83,0
- Geschlecht
- M
- Eingang
- 02.12.2021
- Impfdatum
- 05.11.2021
- Beginn
- 11.11.2021
- Tage bis Beginn
- 6,0
- Dosis
- 1
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: ja
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Arterial haemorrhage
Endoscopy
Endotracheal intubation
Gastrointestinal haemorrhage
Imaging procedure
Intensive care
Laboratory test
Transfusion
Vascular cauterisation
Mesenteric haemorrhage
Symptomtext
Mesenteric arterial gastrointestinal bleed severe; This is a spontaneous report from a contactable nurse. An 83-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), intramuscular, administration date 05Nov2021 10:00 (Lot number: 33026BD) at the age of 83 years as DOSE 1, SINGLE for COVID-19 immunisation, in nursing home/senior living facility. No other vaccine in four weeks. Relevant medical history included: "Chronic DM2" (unspecified if ongoing); "HTN" (unspecified if ongoing); "Gerd" (unspecified if ongoing); "Neuropathy" (unspecified if ongoing). No COVID prior vaccination. Concomitant medications included: ASPRIN; CYMBALTA; LISINOPRIL; TYLENOL; COREG; METFORMIN. The following information was reported: MESENTERIC HAEMORRHAGE (hospitalization, life threatening) with onset 11Nov2021 13:30, outcome "not recovered", described as "Mesenteric arterial gastrointestinal bleed severe". Clinical course: mesenteric arterial gastrointestinal bleed severe, requiring hospitalization w/ transfer to hospital w/higher level of care. ICU Intubated and received multiple units of blood, GI scope w/interventions, currently still hospitalized w/ no estimated discharge date. The patient was hospitalized for mesenteric haemorrhage (hospitalization duration: 7 days). The event "mesenteric arterial gastrointestinal bleed severe" was evaluated at the emergency room visit. Therapeutic measures were taken as a result of mesenteric haemorrhage and included treatment with multiple units of blood. No COVID tested post vaccination; Sender's Comments: Based on the available information in the case, the causal association between the event mesenteric haemorrhage and the suspect drug BNT162B2 cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Intensive care
- Hospital-Tage
- 7,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: GERD; Hypertension; Neuropathy; Type II diabetes mellitus
- Andere Medikamente
- ASPRIN; CYMBALTA; LISINOPRIL; TYLENOL; COREG; METFORMIN
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OR
- Alter
- 25,0
- Geschlecht
- F
- Eingang
- 22.11.2021
- Impfdatum
- 20.11.2021
- Beginn
- 20.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Chills
Dizziness
Fatigue
Feeding disorder
Injection site pain
Joint range of motion decreased
Migraine
Pyrexia
Syncope
Vomiting
Symptomtext
An hour after injection my arm became so sore I could not move it and I became extremely fatigued and dizzy. Within a few hours of those I became nauseous and by 2am I was fevering with chills. The next morning around 8am I still had chills and fainted while walking around my apartment. 11/22 I left home a few hours into my shift because I was vomiting bile, fevering and had chills. I have had a migraine since about 7pm 11/20. It is 3:18pm and I am still fevering with chills intermittently, am having an extremely hard time stating about and I have not been able to eat today.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syncope
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Vertigo, migraines
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 43,0
- Geschlecht
- F
- Eingang
- 18.11.2021
- Impfdatum
- 15.11.2021
- Beginn
- 15.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
Activated partial thromboplastin time normal
Anticoagulant therapy
Blood chloride increased
Blood creatine phosphokinase MB
Blood creatine phosphokinase normal
Blood creatinine normal
Blood electrolytes normal
Blood glucose normal
Blood urea normal
Cardiac telemetry
Chest X-ray normal
Computerised tomogram head normal
Differential white blood cell count normal
Discomfort
Electrocardiogram normal
Facial paralysis
Feeling abnormal
Full blood count
Symptomtext
43-year-old female with history of anxiety and depression presents to the emergency room with complaints of numbness sensation to the left side of her face and left-sided body pain since Monday evening after she received her first dose of the visor Covid vaccine. She states around 6:30 PM Monday evening 2 days ago on 15 November she received her first dose of the visor Covid 19 vaccine. She states approximately 30 minutes later she noted she had some pain to her arm and to her left leg. She then states that she started feeling like her left side of her face was "droopy". She states she just did not feel right. By about 2 hours after the shot she noted that it felt like her left side of her face was numb. She states ultimately she went to bed and the next day yesterday she thought she was a little better but describe that she just kind of felt sore all over. However she persist to feel this numbness sensation to the left side of her face from her eyelid on down the cheek and jaw. She states although it felt like it was heavy and "droopy" when she looked in the mirror she did not notice any facial droop. She states right now it just continues to feel heavy feeling to her. She states yesterday she felt occasional tremulous. She reports she does feel little bit of a numbing sensation to her left upper extremity including her hand. She does not feel any numbness or tingling to her l legs. She states yesterday morning she did have a little bit of blurry vision but has had no vision changes since then. No diplopia. She does report that she feels a little weak on the left side of her body. She denies headache. She denies fever or chills. She denies chest pain, shortness of breath, palpitations, syncope or near syncope feeling. Yesterday she was nauseated but does not have that today. She denies dizziness, lightheadedness, syncope or near syncope feeling. No speech impairment. No history of blood clotting disorder. No history of CVA. She is not on any birth control or hormonal replacement. No exposure to person with Covid-19 positive. Reviewed the MRI of the brain with and without contrast which as read by radiologist shows findings are suspicious for possible right transverse sigmoid sinus thrombosis. No evidence of infarct or other acute intracranial abnormality. Reviewed the MR venous brain without contrast which as read by radiologist shows partial thrombosis right transverse and sigmoid sinus suspected. Remainder of the venous sinuses are widely patent. Recontacted Dr. and reviewed with her the results of the MRI of the brain and MRV of the brain. She recommends admission, anticoagulation with heparin followed by Coumadin. She has recommended coagulopathy work-up in addition which she has ordered additional laboratory testing. Heparin will be started after the additional laboratory testing blood is collected. Reviewed all testing results with the patient and her husband and the limitations of the testing that has been performed today. Discussed with her the recommendation by neurologist Dr. The heparin anticoagulation was started. -Patient be admitted under observation status as neurology would like to have the patient monitor overnight for the cerebral venous sinus thrombosis -Patient be placed on Lovenox and Coumadin and will monitor PT/INR -Neurological checks will be also done every 4 hours -Continue with telemetry monitoring -If patient exhibits any change in her clinical status or neurological symptoms patient will need to have a stroke work-up done starting off with a CT scan of the brain -Echocardiogram ordered -Labs for tomorrow morning ordered and Dr ordered anticoagulation labs -Dr was consulted by emergency room physician
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Facial paralysis
- Hospital-Tage
- 1,0
- Labordaten
- Diagnostic Interpretation (11/17/21) EKG was done, reviewed and showed normal sinus rhythm with sinus arrhythmia. Ventricular rate of 72. No ST elevation or depression. QTC is 378 ms. QRS duration is 82 ms. 1 view chest x-ray was done read by radiologist Dr shows no acute cardiopulmonary process. CT of the brain/head without contrast was done, reviewed and read by radiologist Dr which shows no acute intracranial abnormality. MRI of the brain with and without contrast was done, reviewed and read by radiologist Dr which shows findings are suspicious for possible right transverse sigmoid sinus thrombosis. No evidence of infarct or other acute intracranial abnormality. MRI venous brain without contrast was done, reviewed and read by radiologist Dr which shows partial thrombosis right transverse and sigmoid sinus suspected. Remainder of the venous sinuses are widely patent. CBC: White blood cell count is 6.0 with unremarkable differential. Hemoglobin, hematocrit and platelets are normal. Chemistry profile: Electrolytes are normal with exception of the chloride is elevated at 108. BUN is normal at 10. Creatinine is low at 0.58. Glucose is 75. Liver enzymes are normal. Cardiac profile: CK is normal at 75 with CK-MB of 2.76, CK-MB percent of 3.7 and troponin I normal at less than 0.01. Point-of-care urine pregnancy test: Negative PTT and INR are normal Urinalysis: Normal SARS-CoV-2 (COVID-19) rapid test: Negative
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Anxiety; Depression
- Andere Medikamente
- Phentermine 30 mg Daily; Tumeric 2 caps Daily
- Allergien
- KNA
- Vorherige Impfungen
- -
- Staat
- VA
- Alter
- 23,0
- Geschlecht
- F
- Eingang
- 15.11.2021
- Impfdatum
- 14.11.2021
- Beginn
- 14.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Seizure
Syncope
Unresponsive to stimuli
Symptomtext
Systemic: Fainting / Unresponsive-Mild, Systemic: Seizure-Mild, Additional Details: This lasted about 20 seconds. Patient fainted some seconds after receiving the vaccine. Patient reports previous history of fainting after a vaccine administration.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Seizure
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IN
- Alter
- 16,0
- Geschlecht
- F
- Eingang
- 02.11.2021
- Impfdatum
- 01.11.2021
- Beginn
- 01.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Asthenia
Confusional state
Dizziness
Fall
Fatigue
Hypotension
Lethargy
Pallor
Pyrexia
Syncope
Tremor
Unresponsive to stimuli
Symptomtext
Systemic: Confusion-Medium, Systemic: Dizziness / Lightheadness-Severe, Systemic: Exhaustion / Lethargy-Severe, Systemic: Fainting / Unresponsive-Medium, Systemic: Fever-Medium, Systemic: TREMORS-Medium, Systemic: Hypotension-Medium, Systemic: Shakiness-Medium, Systemic: Weakness-Medium, Additional Details: PT RECEIVED COVID VACCINE AND AFTER 7/15 MINUTES OF MONITORING, PT GOT UP AND FELL OVER, HIT HER HEAD ON A SHELF IN THE STORE. GAVE PT WATER AND HAD HER SIT UP WHEN SHE WAS FEELING LESS DIZZY ONTO THE CHAIR. ABOUT 5 MINUTES LATER PTS MOM REPORTED TREMORS AND PT HAD FALLEN OVER AGAIN. CALLED 911. PT LOOKED PALE AND LETHARGIC. PTS MOM CONSENTED TO ADMINISTRATION OF EPINEPHRINE AND 1 DOSE WAS GIVEN. AFTER 911 WAS CALLED. EMS CAME AND TOOK PT TO HOSPITAL.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syncope
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 31,0
- Geschlecht
- M
- Eingang
- 30.10.2021
- Impfdatum
- 29.10.2021
- Beginn
- 29.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Dizziness
Nausea
Syncope
Unresponsive to stimuli
Vomiting
Symptomtext
Systemic: Dizziness / Lightheadness-Severe, Systemic: Fainting / Unresponsive-Severe, Systemic: Nausea-Medium, Systemic: Vomiting-Mild
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syncope
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 70,0
- Geschlecht
- M
- Eingang
- 15.11.2023
- Impfdatum
- 20.12.2021
- Beginn
- 20.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
Dyspnoea
Symptomtext
Pt stated that he got the vaccine and then hours later pt had issues breathing and had to call EMS and be rushed to the hospital. Pt has history of COPD. Pt was unsure if this is vaccine related or if this occurred from another underlying issue.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- PT HAS HISTORY OF COPD
- Vorgeschichte
- COPD
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NH
- Alter
- 43,0
- Geschlecht
- F
- Eingang
- 15.03.2023
- Impfdatum
- 24.11.2021
- Beginn
- 01.07.2022
- Tage bis Beginn
- 219,0
- Dosis
- 3
- Route/Site
- SYR / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Condition aggravated
Psoriasis
Symptomtext
I noticed a worsening of my symptom following the third dose and new patches of Psoriasis appeared in 14July2022. Clobetasol stopped managing my symptoms and no dietary or stress have occurred.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Condition aggravated
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Psoriasis
- Andere Medikamente
- JUNEL; LEXAPRO; clobetasol; CENTRUM women's; vitamin d; omega 3
- Allergien
- ACCUTANE
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 85,0
- Geschlecht
- M
- Eingang
- 10.01.2023
- Impfdatum
- 05.03.2021
- Beginn
- 12.12.2022
- Tage bis Beginn
- 647,0
- Dosis
- 3
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19
Cough
Dizziness
Dyspnoea
Nausea
Respiratory tract congestion
SARS-CoV-2 test positive
Symptomtext
12/12/22 presents to ED for "dizziness" "cough, congestion, nausea and SOB". PMHx of "OSA on CPAP, diverticulitis, SSS s/p PPM"
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- -
- Labordaten
- 12/12/22 SARS-CoV-2 (COVID-19) by NAA detected
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 80,0
- Geschlecht
- M
- Eingang
- 24.10.2022
- Impfdatum
- 14.01.2021
- Beginn
- 01.09.2022
- Tage bis Beginn
- 595,0
- Dosis
- 3
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19
Dyspnoea
SARS-CoV-2 test positive
Symptomtext
09/01/22 presents to ED for "shortness of breath". PMHx of "CAD, GERD, hypertension, diabetes, peripheral artery disease, abdominal aortic aneurysm"
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- -
- Labordaten
- 09/01/22 SARS-CoV-2 (COVID-19) by NAA detected
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 57,0
- Geschlecht
- F
- Eingang
- 08.09.2022
- Impfdatum
- 07.01.2021
- Beginn
- 09.08.2022
- Tage bis Beginn
- 579,0
- Dosis
- 3
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: ja
COVID-19
Dehydration
Diarrhoea
Dizziness
Hallucination
Head discomfort
Headache
Musculoskeletal stiffness
Nausea
Oesophagogastric fundoplasty
Phonophobia
Photophobia
Resting tremor
SARS-CoV-2 test positive
Tinnitus
Tremor
Vomiting
Symptomtext
58y.o. female who presented to Hospital on 8/9/22 N/V & Diarrhea. She was seen at Facility 8/8, given fluids, dx with dehydration, subsequently discharged home. Pt states PCP sent her To EC for further evaluation due to chronic N/V x two years. Pt states she had a fundoplication Feb 2022. Pt was recently COVID+ at end of July.The patient is complaining of headache for couple months. The headache describe as pressure/throbbing in type and located across the R temporal head region and base of the head and graded 10/10. The past week, the headache comes lasts all day. The headache is associate with neck stiffness, photo-phonophobia, tinnitus, nausea, vomiting, and dizziness. At home, patient stated that rest and Tylenol help the headache. Fioricet helps bring the headache to +2-3 out of 10. There was no history of head injury, fall, trauma, nasal or ear discharge, blurring vision, diplopia, dysarthria, facial or extremities numbness or weakness. The patient is also complaining of hands tremor for 1 month. The patient stated that the tremor has been progressively worsening and gets worse with moving the hands include holding the phone. The hand resting tremor is worse over the left hand. The pt states she has hallucinations. There is family hx of Parkinsons (sister).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dehydration
- Hospital-Tage
- 4,0
- Labordaten
- 8/9 SARS-CoV-2 (COVID-19) by Nucleic Acid Amplification, POC --detected
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 54,0
- Geschlecht
- M
- Eingang
- 08.06.2022
- Impfdatum
- 29.11.2021
- Beginn
- 20.05.2022
- Tage bis Beginn
- 172,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: ja
COVID-19
Dyspnoea
Hypoxia
Symptomtext
Patient presented to the hospital for dyspnea and hypoxemia and found to have COVID. Patient was started on supplemental oxygen and decadron,
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- 2,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- DM2, AKI, HTN
- Andere Medikamente
- elavil, lipitor, gabapentin, victoza, metformin, prilosec
- Allergien
- Latex
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 58,0
- Geschlecht
- F
- Eingang
- 21.04.2022
- Impfdatum
- 24.03.2021
- Beginn
- 18.04.2022
- Tage bis Beginn
- 390,0
- Dosis
- 3
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: ja
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: ja
Angiogram cerebral abnormal
Arteriogram carotid abnormal
Carotid artery aneurysm
Cerebral disorder
Chest pain
Computerised tomogram head abnormal
Gastrooesophageal reflux disease
Nausea
Paraesthesia
Subarachnoid haemorrhage
Vascular pseudoaneurysm
Symptomtext
Patient began having nausea, reflux, hand tingling and chest pain on 4/18. CT head 4/18: showed trace SAH with high left frontal parietal sulci. CTA head/neck: 1.5 mm aneurysm of proximal L cavernous ICA with small pseudoaneurysm of the posterior proximal ICA. NIR - no source of bleed found
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chest pain
- Hospital-Tage
- 2,0
- Labordaten
- see above.
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 56,0
- Geschlecht
- F
- Eingang
- 17.04.2022
- Impfdatum
- 08.11.2021
- Beginn
- 08.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Blood test
Burning sensation
Cerebral disorder
Dizziness
Electromyogram abnormal
Hypoaesthesia
Immediate post-injection reaction
Injection site pain
Magnetic resonance imaging head abnormal
Nerve conduction studies abnormal
Neurological examination abnormal
Pain in extremity
Paraesthesia
Skin burning sensation
Tachycardia
Tremor
Vertigo
Vision blurred
Symptomtext
Immediate burning sensation in length of both arms and both legs. Lasted one week. Reemerged 7 weeks later with severe intensity. Severe burning at injection site, upper lateral right arm, and lateral side both legs, right elbow and forearm, crown of head, face, bridge of nose, severe burning on tops of feet and hands. Numbness and tingling soles of feet and palms of hands. Sensation of having been hit by a hammer in fingers. Shaking from pain. Blurry vision in lateral side of right eye. Extreme dizziness. Room spinning sensation. Tachycardia at 140 pulse at rest.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Paraesthesia
- Hospital-Tage
- -
- Labordaten
- EMG and nerve conductivity tests with neurologist February 2022. Bloodwork Febuary 2022. EMG/NC tests showed ulnar abnormality right forearm. Brain MRI after positive Clonus side. Showed white matter abnormality.
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- Hashimoto? thyroiditis
- Andere Medikamente
- synthroid
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 55,0
- Geschlecht
- F
- Eingang
- 16.03.2022
- Impfdatum
- 09.12.2021
- Beginn
- 09.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- - / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Dizziness
Fatigue
Headache
Heart rate
Heart rate increased
Insomnia
Myalgia
Palpitations
Symptomtext
Pounding heart in my chest for 3-4 hours at bedtime before I took a gabapentin to finally fall asleep. Seemed like my heart rate was very, very rapid. I could not settle my heart rate down at all; I woke up feeling very tired; still with a very sore right arm muscle; a bad headache; as well as dizziness; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 55 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 09Dec2021 14:45 (Lot number: 33026BD) at the age of 55 years as dose 2 (booster), single for covid-19 immunization. Relevant medical history included: "My heart rate does get elevated/races after drinking alcohol (any type) '||CHR(38)||' caffeine. Otherwise very healthy" (unspecified if ongoing), notes: My heart rate does get elevated/races after drinking alcohol (any type) & caffeine. Otherwise very healthy; "Allergy: beeswax in lip balms" (unspecified if ongoing). The patient took concomitant medications. Vaccination history included: Johnson & Johnson (Dose Number: 1, Batch/Lot No: 043A21A, Location of injection: Arm Right, Vaccine Administration Time: 02:00 PM), administration date: 28May2021, when the patient was 54 years old, for COVID-19 immunization. The following information was reported: HEART RATE INCREASED (non-serious) with onset 09Dec2021 23:00, outcome "recovering", described as "Pounding heart in my chest for 3-4 hours at bedtime before I took a gabapentin to finally fall asleep. Seemed like my heart rate was very, very rapid. I could not settle my heart rate down at all"; FATIGUE (non-serious) with onset 09Dec2021 23:00, outcome "recovering", described as "I woke up feeling very tired"; MYALGIA (non-serious) with onset 09Dec2021 23:00, outcome "recovering", described as "still with a very sore right arm muscle"; HEADACHE (non-serious) with onset 09Dec2021 23:00, outcome "recovering", described as "a bad headache"; DIZZINESS (non-serious) with onset 09Dec2021 23:00, outcome "recovering", described as "as well as dizziness". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of heart rate increased. Therapeutic measures were not taken as a result of fatigue, myalgia, headache, dizziness. Additional information:Pounding heart in my chest for 3-4 hours at bedtime before I took a gabapentin to finally fall asleep. Seemed like my heart rate was very, very rapid. I could not settle my heart rate down at all. However I did take my own heart rate & it was only in the upper 60s bpm, so I did not go to the ER. But it still felt like my heart was working twice as hard as normal. I woke up feeling very tired, still with a very sore right arm muscle, a bad headache, as well as dizziness. But my heart rate was not elevated in the morning. Follow-Up (15Dec2021): Follow-up attempts are completed. No further information is expected. No follow-up attempts are possible. No further information is expected.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Palpitations
- Hospital-Tage
- -
- Labordaten
- Test Date: 20211209; Test Name: heart rate; Result Unstructured Data: Test Result:upper 60s bpm; Comments: I did take my own heart rate & it was only in the upper 60s bpm, so I did not go to the ER
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Allergy; Heart racing (My heart rate does get elevated/races after drinking alcohol (any type) & caffeine. Otherwise very healthy)
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 55,0
- Geschlecht
- F
- Eingang
- 16.03.2022
- Impfdatum
- 09.12.2021
- Beginn
- 09.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Dizziness
Fatigue
Headache
Heart rate
Heart rate increased
Insomnia
Myalgia
Palpitations
Symptomtext
Pounding heart in my chest for 3-4 hours at bedtime before I took a gabapentin to finally fall asleep. Seemed like my heart rate was very, very rapid. I could not settle my heart rate down at all; I woke up feeling very tired; still with a very sore right arm muscle; a bad headache; as well as dizziness; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 55 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 09Dec2021 14:45 (Lot number: 33026BD) at the age of 55 years as dose 2 (booster), single for covid-19 immunization. Relevant medical history included: "My heart rate does get elevated/races after drinking alcohol (any type) '||CHR(38)||' caffeine. Otherwise very healthy" (unspecified if ongoing), notes: My heart rate does get elevated/races after drinking alcohol (any type) & caffeine. Otherwise very healthy; "Allergy: beeswax in lip balms" (unspecified if ongoing). The patient took concomitant medications. Vaccination history included: Johnson & Johnson (Dose Number: 1, Batch/Lot No: 043A21A, Location of injection: Arm Right, Vaccine Administration Time: 02:00 PM), administration date: 28May2021, when the patient was 54 years old, for COVID-19 immunization. The following information was reported: HEART RATE INCREASED (non-serious) with onset 09Dec2021 23:00, outcome "recovering", described as "Pounding heart in my chest for 3-4 hours at bedtime before I took a gabapentin to finally fall asleep. Seemed like my heart rate was very, very rapid. I could not settle my heart rate down at all"; FATIGUE (non-serious) with onset 09Dec2021 23:00, outcome "recovering", described as "I woke up feeling very tired"; MYALGIA (non-serious) with onset 09Dec2021 23:00, outcome "recovering", described as "still with a very sore right arm muscle"; HEADACHE (non-serious) with onset 09Dec2021 23:00, outcome "recovering", described as "a bad headache"; DIZZINESS (non-serious) with onset 09Dec2021 23:00, outcome "recovering", described as "as well as dizziness". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of heart rate increased. Therapeutic measures were not taken as a result of fatigue, myalgia, headache, dizziness. Additional information:Pounding heart in my chest for 3-4 hours at bedtime before I took a gabapentin to finally fall asleep. Seemed like my heart rate was very, very rapid. I could not settle my heart rate down at all. However I did take my own heart rate & it was only in the upper 60s bpm, so I did not go to the ER. But it still felt like my heart was working twice as hard as normal. I woke up feeling very tired, still with a very sore right arm muscle, a bad headache, as well as dizziness. But my heart rate was not elevated in the morning. Follow-Up (15Dec2021): Follow-up attempts are completed. No further information is expected. No follow-up attempts are possible. No further information is expected.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Palpitations
- Hospital-Tage
- -
- Labordaten
- Test Date: 20211209; Test Name: heart rate; Result Unstructured Data: Test Result:upper 60s bpm; Comments: I did take my own heart rate & it was only in the upper 60s bpm, so I did not go to the ER
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Allergy; Heart racing (My heart rate does get elevated/races after drinking alcohol (any type) & caffeine. Otherwise very healthy)
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 26,0
- Geschlecht
- F
- Eingang
- 21.01.2022
- Impfdatum
- 01.12.2021
- Beginn
- 01.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- SYR / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Blood test
Chest pain
Dyspnoea
Electrocardiogram
Heart rate increased
Symptomtext
Beginning in mid-December, I began to experienced increased heart rate and occasional breathlessness. I have a little soreness in my chest. I saw a doctor today and had a few tests and was referred to a cardiologists for additional testing.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chest pain
- Hospital-Tage
- -
- Labordaten
- Bloodwork and EKG.
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- Sprintec birth control, allegra
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- MN
- Alter
- 63,0
- Geschlecht
- F
- Eingang
- 14.01.2022
- Impfdatum
- 10.11.2021
- Beginn
- 13.11.2021
- Tage bis Beginn
- 3,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Blood test
Burning sensation
Neuralgia
Pain
Paraesthesia
Symptomtext
Three days after getting the booster, I started feeling tingling/burning sensations all over my body. When it became fairly intense (especially in my feet, legs and hands), I went to the ER. They did some blood work, etc., sent me home and told me to see my primary care doctor. When I returned home, I again ended up in the ER before I could get in to see my primary. My primary did a bunch of blood work and told me to see a neurologist. I am currently working with two neurologists trying to figure out what is going on with me. I have been through numerous tests and probably in for even more! Two months now and still in pain! On gabapentin for the nerve pain!
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Paraesthesia
- Hospital-Tage
- -
- Labordaten
- Too many to list! Contact doctor above!
- Aktuelle Erkrankungen
- Low back pain
- Vorgeschichte
- Possibly fibromyalgia but never treated for it. Primary 30 years ago said posibly but then another doctor said no.
- Andere Medikamente
- Tamoxifen, Vitamin D, Calcium, Vitamin C, probiotic
- Allergien
- Cipro, Flagyl, Wellbutrin, mollusks
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 41,0
- Geschlecht
- F
- Eingang
- 13.01.2022
- Impfdatum
- 12.01.2022
- Beginn
- 12.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Dizziness
Hypertension
Symptomtext
Pt received 1st dose of Adult Pfizer 0.3ml Via IM at 1325. Pt reported feeling gonna faint. Pt High BP noted 170/108 ,Pulse 90 , Resp 20. O2 100% . Pt verbally responsive and no facial color changes and no SOB noted. Vitals checked again BP 154/95, Pulse 83, Resp 18, O2 100% Fluids given and well tolerated. Physician contacted and pt evaluated by physcian and advice to contact PCP
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Hypertension
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- HTN
- Andere Medikamente
- N/A
- Allergien
- N/A
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 42,0
- Geschlecht
- F
- Eingang
- 01.01.2022
- Impfdatum
- 18.11.2021
- Beginn
- 18.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Condition aggravated
Fatigue
Migraine
Nausea
Symptomtext
At 3pm, I was very nauseous and stayed that way for the rest of the night. Upon waking the next morning, I woke up with a migraine that persisted for the next 6 days. When waking on 11/25, my migraine was gone. I have also experienced consistent fatigue since getting the dose that persists to this day.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Condition aggravated
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- N/a
- Vorgeschichte
- Acid reflux, migraines
- Andere Medikamente
- Nexium, Adderall, Baclofen, Buproprion, Claritin, women's probiotic (Renew Life).
- Allergien
- LEVAQUIN
- Vorherige Impfungen
- 4/27/21. Second dose of covid vaccine by Pfizer, I experience a migraine the following 2 days and consistent fatigue for about
- Staat
- NC
- Alter
- 49,0
- Geschlecht
- F
- Eingang
- 19.12.2021
- Impfdatum
- 07.11.2021
- Beginn
- 07.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injection site hypoaesthesia
Injection site pain
Injection site paraesthesia
Loss of personal independence in daily activities
Pain
Pain in extremity
Symptomtext
Extreme muscle soreness, tingles, numbness and overall pain at the injection site, past my elbow. Hurts to raise my arm for every day living and practice piano.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site paraesthesia
- Hospital-Tage
- -
- Labordaten
- Visited my primary care doctor, (NAME) on 12/15 who will advise on next steps.
- Aktuelle Erkrankungen
- No
- Vorgeschichte
- Dermatomyositis
- Andere Medikamente
- Ashgawanda, turmeric, maca
- Allergien
- No
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 24,0
- Geschlecht
- F
- Eingang
- 17.12.2021
- Impfdatum
- 15.12.2021
- Beginn
- 16.12.2021
- Tage bis Beginn
- 1,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Chills
Fatigue
Migraine
Myalgia
Pyrexia
Symptomtext
Fatigue, chills, fever, muscle aches, migraine
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Migraine
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- Birth control
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 65,0
- Geschlecht
- F
- Eingang
- 10.12.2021
- Impfdatum
- 05.11.2021
- Beginn
- 05.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- - / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Extra dose administered
Vaccine positive rechallenge
Headache
Illness
Immunisation
Lymph node pain
Lymphadenopathy
Migraine
Pain
Pyrexia
Symptomtext
Shot 3 - extreme illness; High fever; Horrendous headache; Body aches; Lymph nodes swollen and sore; Lymph nodes swollen and sore; Dose Number 3; Horrendous migraines; This is a spontaneous report received from a contactable reporter (Consumer) for a Pfizer sponsored program (005570). The reporter is the patient. This is the first of three reports. A 65-year-old female patient (not pregnant) received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), administered in arm right, administration date 05Nov2021 16:00 (Lot number: 33026BD) at the age of 65 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Migraines" (unspecified if ongoing); "Extreme sensitivity to medications" (unspecified if ongoing). There were no concomitant medications. Vaccination history included: Bnt162b2 (Dose: 1 Batch/Lot No: EW0161; Arm Left; time: 04:00 PM), administration date: 16Apr2021, when the patient was 64 years old, for COVID-19 Immunization, reaction(s): "very sick for 3 days", "Fever", "Headache", "Body aches", "Lymph node soreness"; Bnt162b2 (Dose: 2 Batch/Lot No: ER8731; Arm Left; Time: 04:00 PM), administration date: 07May2021, when the patient was 64 years old, for COVID-19 Immunization, reaction(s): "Much worse 4 days", "Higher fever", "Bad headache", "Body aches", "Lymph nodes swollen for 60 days". The following information was reported: IMMUNISATION (non-serious) with onset 05Nov2021 16:00, outcome "unknown", described as "Dose Number 3"; ILLNESS (non-serious) with onset 05Nov2021 20:00, outcome "not recovered", described as "Shot 3 - extreme illness"; PYREXIA (non-serious) with onset 05Nov2021 20:00, outcome "not recovered", described as "High fever"; HEADACHE (non-serious) with onset 05Nov2021 20:00, outcome "not recovered", described as "Horrendous headache"; PAIN (non-serious) with onset 05Nov2021 20:00, outcome "not recovered", described as "Body aches"; LYMPH NODE PAIN (non-serious), LYMPHADENOPATHY (non-serious) all with onset 05Nov2021 20:00, outcome "not recovered" and all described as "Lymph nodes swollen and sore"; MIGRAINE (non-serious) with onset 2021, outcome "unknown", described as "Horrendous migraines". Therapeutic measures were not taken as a result of illness, pyrexia, headache, pain, lymph node pain, lymphadenopathy. Additional information: No other medications in two weeks and no other vaccine in four weeks. Facility where the most recent COVID-19 vaccine was administered: Pharmacy or Drug Store. The patient had no covid prior vaccination and not covid tested post vaccination. The patient added: "Please help me. I have had 3 Pfizer COVID vaccines and get so very sick with each one, but the Booster has been so bad that I feel I'm dying, literally, and the side effects of high fever, horrendous migraines, horrible body aches go on for many days and weeks. My lymph nodes are swollen for about 2 months. Please help me." Follow-up attempts are completed. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101646795 Same reporter, patient, product; Different dose, events;US-PFIZER INC-202101647144 Same reporter, patient, product; Different dose, events
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Migraine
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Drug hypersensitivity; Migraine
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 65,0
- Geschlecht
- F
- Eingang
- 10.12.2021
- Impfdatum
- 05.11.2021
- Beginn
- 05.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- SYR / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Extra dose administered
Vaccine positive rechallenge
Headache
Illness
Immunisation
Lymph node pain
Lymphadenopathy
Migraine
Pain
Pyrexia
Symptomtext
Shot 3 - extreme illness; High fever; Horrendous headache; Body aches; Lymph nodes swollen and sore; Lymph nodes swollen and sore; Dose Number 3; Horrendous migraines; This is a spontaneous report received from a contactable reporter (Consumer) for a Pfizer sponsored program (005570). The reporter is the patient. This is the first of three reports. A 65-year-old female patient (not pregnant) received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), administered in arm right, administration date 05Nov2021 16:00 (Lot number: 33026BD) at the age of 65 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Migraines" (unspecified if ongoing); "Extreme sensitivity to medications" (unspecified if ongoing). There were no concomitant medications. Vaccination history included: Bnt162b2 (Dose: 1 Batch/Lot No: EW0161; Arm Left; time: 04:00 PM), administration date: 16Apr2021, when the patient was 64 years old, for COVID-19 Immunization, reaction(s): "very sick for 3 days", "Fever", "Headache", "Body aches", "Lymph node soreness"; Bnt162b2 (Dose: 2 Batch/Lot No: ER8731; Arm Left; Time: 04:00 PM), administration date: 07May2021, when the patient was 64 years old, for COVID-19 Immunization, reaction(s): "Much worse 4 days", "Higher fever", "Bad headache", "Body aches", "Lymph nodes swollen for 60 days". The following information was reported: IMMUNISATION (non-serious) with onset 05Nov2021 16:00, outcome "unknown", described as "Dose Number 3"; ILLNESS (non-serious) with onset 05Nov2021 20:00, outcome "not recovered", described as "Shot 3 - extreme illness"; PYREXIA (non-serious) with onset 05Nov2021 20:00, outcome "not recovered", described as "High fever"; HEADACHE (non-serious) with onset 05Nov2021 20:00, outcome "not recovered", described as "Horrendous headache"; PAIN (non-serious) with onset 05Nov2021 20:00, outcome "not recovered", described as "Body aches"; LYMPH NODE PAIN (non-serious), LYMPHADENOPATHY (non-serious) all with onset 05Nov2021 20:00, outcome "not recovered" and all described as "Lymph nodes swollen and sore"; MIGRAINE (non-serious) with onset 2021, outcome "unknown", described as "Horrendous migraines". Therapeutic measures were not taken as a result of illness, pyrexia, headache, pain, lymph node pain, lymphadenopathy. Additional information: No other medications in two weeks and no other vaccine in four weeks. Facility where the most recent COVID-19 vaccine was administered: Pharmacy or Drug Store. The patient had no covid prior vaccination and not covid tested post vaccination. The patient added: "Please help me. I have had 3 Pfizer COVID vaccines and get so very sick with each one, but the Booster has been so bad that I feel I'm dying, literally, and the side effects of high fever, horrendous migraines, horrible body aches go on for many days and weeks. My lymph nodes are swollen for about 2 months. Please help me." Follow-up attempts are completed. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101646795 Same reporter, patient, product; Different dose, events;US-PFIZER INC-202101647144 Same reporter, patient, product; Different dose, events
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Migraine
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Drug hypersensitivity; Migraine
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 37,0
- Geschlecht
- F
- Eingang
- 25.11.2021
- Impfdatum
- 22.11.2021
- Beginn
- 23.11.2021
- Tage bis Beginn
- 1,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Axillary pain
Breast pain
Chest pain
Pain in extremity
Symptomtext
Patient called me on 11/24/21 and informed me that she got the shot on 11/22/21 at 1 pm and she started having reaction on 11/23/21 at 9 pm. She had pain in left arm, left armpits and chest pain and pain was radiating to left arm and left side of breast, also soreness on left arm.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chest pain
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 51,0
- Geschlecht
- M
- Eingang
- 24.11.2021
- Impfdatum
- 22.11.2021
- Beginn
- 23.11.2021
- Tage bis Beginn
- 1,0
- Dosis
- 3
- Route/Site
- SYR / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Hyperhidrosis
Influenza like illness
Mobility decreased
Myalgia
Pyrexia
Symptomtext
Severe flu like symptoms that lasted for about 24 hours.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Mobility decreased
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- This was from the booster. The following I started to get mild flu like symptoms, but as the day progress the symptoms became worse. The flu like symptoms became to the point were I was unable to do anything. I would classify them as severe with a slight fever. Along with muscle soreness in every muscle group. It start in my arms and legs and moved to my chest and back. Tired 400mg of Ibuprofen, which worked at first then as the day progressed if was no longer effective. This continued through out the evening into the night. In the over night I was still feeling the severe symptoms and was sweating through my clothes. I actually had to change t-shirts during the night. Now it's morning as I write this and the symptoms are significantly less and I would consider mild but still present. Did not have any of this for the first 2 shots 6 months ago. Also to I had the flu shot on Nov 4th 2021. One last note- if every future booster is going to be like this I might try a different one rather than go through this again.
- Vorgeschichte
- Diabetes Type2
- Andere Medikamente
- Metformin hcl 500mg Once Per Day Rosuvaatatin usp 5mg OPD Lossrtan Potassium 50mg OPD
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 37,0
- Geschlecht
- F
- Eingang
- 23.11.2021
- Impfdatum
- 16.11.2021
- Beginn
- 16.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Blood test
Injection site urticaria
Throat tightness
Urticaria
Dysphagia
Dyspnoea
Injection site erythema
Injection site swelling
Symptomtext
After injection of 1st Pfizer covid vaccine, my throat began to close. Hives formed on my back and near injection site. I took allergy medication and had to administer my epipen. Within 20mins.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- -
- Labordaten
- Blood work 11/16/2021 11/23/2021
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- -
- Allergien
- Morphine, milk, bees, peanuts, tree pollen, dust, cats, dogs, roaches, grass, ragweed.
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 68,0
- Geschlecht
- F
- Eingang
- 22.11.2021
- Impfdatum
- 11.11.2021
- Beginn
- 11.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- N/A
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Abdominal discomfort
Malaise
Neuralgia
Paraesthesia oral
Symptomtext
Thursday soon after booster: Tingling above lip and then around left side of face where have residual shingles nerve irritation (from 10 years ago). Saturday felt generally unwell with upset stomach.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Paraesthesia oral
- Hospital-Tage
- -
- Labordaten
- NA
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- Formaldyhide, wheat, airborne allergies.
- Vorherige Impfungen
- March 19, 2021 J&J vaccine. Reported to VAERS--see 401649.
- Staat
- TX
- Alter
- 69,0
- Geschlecht
- F
- Eingang
- 15.11.2021
- Impfdatum
- 08.11.2021
- Beginn
- 10.11.2021
- Tage bis Beginn
- 2,0
- Dosis
- 1
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Palpitations
Tachycardia
Tinnitus
Symptomtext
Tachicardia diagnosed by doctor starting on third day after vaccination in the a.m., heart pounding hard and feel it pounding throughout upper body and back. Evening of third day after vaccination severe Tinnitus of both ears, came on suddenly and has not stopped and now in 6th day of these adverse reactions. I had a full workup with my cardiologist in the summer of 2021 and my heart was very healthy with no issues. Have no previous problems with my ears, in fact have had excellent hearing up to now. no treatments have been taken by my doctor. Cardiologist
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Palpitations
- Hospital-Tage
- -
- Labordaten
- nothing has been ordered by doctor
- Aktuelle Erkrankungen
- celiac, ibs, anxiety
- Vorgeschichte
- celiac
- Andere Medikamente
- Lorazepam 1mg at bedtime, Flinestone vitamin at breakfast
- Allergien
- latex, aspirin, sulphur drugs, some antibiotics, codeine, dairy, gluten
- Vorherige Impfungen
- mild case of GBD, age 53, flu shot, 2004
- Staat
- IL
- Alter
- 95,0
- Geschlecht
- F
- Eingang
- 12.11.2021
- Impfdatum
- 10.11.2021
- Beginn
- 11.11.2021
- Tage bis Beginn
- 1,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: ja
Dyspnoea
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- 1,0
- Labordaten
- none
- Aktuelle Erkrankungen
- G30.9ALZHEIMER'S DISEASE, PERSONAL HISTORY OF COVID-19, OTHER ATHEROSCLEROSIS OF NATIVE ARTERIES OF EXTREMITIES, BILATERALLEGS, HISTORY OF FALLING, OTHER PULMONARY EMBOLISM WITHOUT ACUTE COR PULMONALE, UNSPECIFIED DIASTOLIC (CONGESTIVE) HEART FAILURE, TINEA UNGUIUM, NONEXUDATIVE AGE-RELATED MACULAR DEGENERATION, BILATERAL,ADVANCED ATROPHIC WITH SUBFOVEAL INVOLVEMENT, PRESENCE OF INTRAOCULAR LEN, SENSORINEURAL HEARING LOSS, UNILATERAL, LEFT EAR, WITHUNRESTRICTED HEARING ON THE CONTRALATERAL SIDE, MIXED CONDUCTIVE AND SENSORINEURAL HEARING LOSS, UNILATERAL,RIGHT EAR, WITH UNRESTRICTED HEARING ON THE CONTRALATERAL SIDE, ANTICOAGULANT SYNDROME, OBESITY, UNSPECIFIED, HYPERLIPIDEMIA, UNSPECIFIED, DEMENTIA IN OTHER DISEASES CLASSIFIED ELSEWHERE WITHOUTBEHAVIORAL DISTURBANCE, ESSENTIAL (PRIMARY) HYPERTENSION, CONSTIPATION, UNSPECIFIED PRIMARY GENERALIZED (OSTEO)ARTHRITIS, UNSPECIFIED URINARY INCONTINENCE.
- Vorgeschichte
- CHRONIC OBSTRUCTIVE PULMONARY DISEASE, GASTRO-ESOPHAGEAL REFLUX DISEASE WITHOUT ESOPHAGITIS AND PERSONAL HISTORY OF PULMONARY EMBOLISM.
- Andere Medikamente
- ACETAMINOPHEN TABLET 325mg DOCUSATE SODIUM TABLET 100MG PSYLLIUM HUSK POWDER SPIRONOLACTONE TABLET 25mg TOPROL XL TABLET EXTENDED RELEASE 24 HOURS 25 MG WARFARIN SODIUM TABLET
- Allergien
- No known allergies
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 30,0
- Geschlecht
- M
- Eingang
- 06.11.2021
- Impfdatum
- 05.11.2021
- Beginn
- 06.11.2021
- Tage bis Beginn
- 1,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Chest pain
Chills
Headache
Insomnia
Pyrexia
Tachycardia
Symptomtext
Tachycardia (110 bpm supine at rest), chest pain, fever (100.3?F), headache, chills and insomnia. All symptoms with onset around 2:00 am on 11/6/2021.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chest pain
- Hospital-Tage
- -
- Labordaten
- None.
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- 61,0
- Geschlecht
- F
- Eingang
- 10.05.2023
- Impfdatum
- 05.11.2021
- Beginn
- 07.11.2021
- Tage bis Beginn
- 2,0
- Dosis
- 3
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: ja
ER: unbekannt
Erholt: nein
Anxiety
Brain fog
Depression
Fall
Fatigue
Gait disturbance
Magnetic resonance imaging
Musculoskeletal disorder
Pain
Pruritus
X-ray
Symptomtext
Brain Itch Brain Fog Exhaustion Anxiety Depression Pain Extreme Pain Walking Issues Falling Leg moving to left when going straight
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Fatigue
- Hospital-Tage
- -
- Labordaten
- MRI 2/28/23 Pain Med/xrays 3/19/23
- Aktuelle Erkrankungen
- NA
- Vorgeschichte
- NA
- Andere Medikamente
- NA
- Allergien
- NA
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 61,0
- Geschlecht
- M
- Eingang
- 01.02.2023
- Impfdatum
- 09.12.2022
- Beginn
- 02.01.2023
- Tage bis Beginn
- 24,0
- Dosis
- 3
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19
Pyrexia
SARS-CoV-2 test positive
Symptomtext
01/02/23 presents to ED for "fever". PMHx of "HIV/AIDS, hx of syphillis, Hep B chronic infection"
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pyrexia
- Hospital-Tage
- -
- Labordaten
- 01/02/23 SARS-CoV-2 (COVID-19) by NAA detected
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 67,0
- Geschlecht
- F
- Eingang
- 21.12.2022
- Impfdatum
- 18.11.2021
- Beginn
- 05.12.2022
- Tage bis Beginn
- 382,0
- Dosis
- 3
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19
Malaise
Pyrexia
SARS-CoV-2 test positive
Sepsis
Symptomtext
Hospitalization: 12/4/2022 - 12/8/2022 (4 days) Presentation to the ED: generalized malaise, fever. ADMITTED FOR SEPSIS. COVID + date: 12/5/2022. Treatment: bronchodilators, systemic steroids, remdesivir. Discharge to: SNF Pfizer Lot # EN6199 3/11/2021 Pfizer Lot # EP6955 4/1/2021 Pfizer Lot # 33026BD 11/18/2021
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Malaise
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- T2D, BREAST CANCER IN REMISSION, CKD - III, GERD, HTN.
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 32,0
- Geschlecht
- F
- Eingang
- 06.12.2022
- Impfdatum
- 13.03.2021
- Beginn
- 28.10.2022
- Tage bis Beginn
- 594,0
- Dosis
- 3
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Abortion spontaneous
Exposure during pregnancy
Foetal growth restriction
Foetal heart rate abnormal
Ultrasound antenatal screen abnormal
COVID-19
Cough
Foetal hypokinesia
Gestational diabetes
Oropharyngeal pain
SARS-CoV-2 test positive
Symptomtext
10/29/22 presents to Triage for "decreased fetal movement in Baby B" "32w1d" " "nonproductive cough and sore throat" "gestational diabetes" PMHx of "ADHD, Hashimoto's thyroiditis, asthma"
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Oropharyngeal pain
- Hospital-Tage
- -
- Labordaten
- 10/29/22 SARS-CoV-2 (COVID-19) by NAA detected
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OR
- Alter
- 53,0
- Geschlecht
- M
- Eingang
- 30.11.2022
- Impfdatum
- 29.11.2021
- Beginn
- 01.12.2021
- Tage bis Beginn
- 2,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Balance disorder
Bedridden
Decreased appetite
Dizziness
Dysstasia
Gait inability
Loss of personal independence in daily activities
Nausea
Vertigo
Visual impairment
Vomiting
Symptomtext
I received my first Pfizer booster for COVID-19 on 11/29/2021. During the last week of December 2021 or the first week of January 2022, I developed vertigo. The first thing I noticed was that my vision was spinning and drifting. It made me nauseous, and I threw up. I had to lie down and close my eyes. I was mostly bedridden for about a week as a result of the condition. I had very little appetite at the time. The intensity of the vertigo varied, but most of the time, I was unable to stand or walk, so I ended up staying in bed for most of the day. Within a couple of days of the onset of the vertigo, I spoke with someone at the cardiology clinic I go to. He told me that he didn't think the vertigo was related to my pre-existing heart condition. He also said that he and his colleagues were aware of there being more cases of people reporting vertigo attacks, but they didn't know what caused it. I asked him if the vertigo could be related to the Pfizer booster I had received a month earlier, but he said that he didn't know. Within 2 days of the onset of the vertigo, I was able to get out of bed briefly for a few hours, only to have the vertigo worsen again and send me back to bed. This pattern continued for the next 4 or 5 days. That is, I would be able to get out of bed for a few hours with light dizziness and shaky balance, only to have the vertigo come back and send me back to bed. After a week of this, I was well enough to do most things, but my vision would still rotate a little. My vision and my balance were a little uneven for about a month afterwards, but I was still able to engage in most of my regular activities. During this time, I spoke to a nutritionist colleague about my condition. He suggested that I try taking menhaden fish oil, because he had recently used it to treat several other people for vertigo, and it had helped resolve their issue within a couple of days of their taking it. He also suggested that I eat zante currants and take peanut butter oil, which I did. He said that these would probably help, since they would help build up the production of myelin sheath in the nervous system. Within a day or two after trying the fish oil, I felt markedly better and I was able to return to my normal activities. I have been taking the fish oil ever since, and I think I have made a complete recovery from the vertigo.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dizziness
- Hospital-Tage
- -
- Labordaten
- None.
- Aktuelle Erkrankungen
- None.
- Vorgeschichte
- Hypertension; Blocked Artery Treated with Stent Insertion; Hereditary Earwax Build-up.
- Andere Medikamente
- Clopidogrel; amlodipine besylate; candesartan; atorvastatin; metoprolol succinate; aspirin.
- Allergien
- None.
- Vorherige Impfungen
- -
- Staat
- ME
- Alter
- 67,0
- Geschlecht
- F
- Eingang
- 12.11.2022
- Impfdatum
- 05.11.2021
- Beginn
- 01.02.2022
- Tage bis Beginn
- 88,0
- Dosis
- 3
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Biopsy skin abnormal
Dermatitis
Inability to afford medication
Influenza like illness
Rash pruritic
Symptomtext
I experienced mild flu-like symptoms the next day. In February 2022 I developed an itchy, bumpy rash on the back of my head. It spread over the next few weeks to my neck and shoulder, around my waist and on both elbows. I saw my PCP in March and she prescribed steroidal cream for the itch. She increased the strength of the topical twice in the next 2 months and then referred me to a dermatologist. I saw him in July 2022 and he told me it was a reaction to the booster. He prescribed another topical, Clobetasol Propionate Foam .05%, which helped with the itch, but not the rash. He then gave me a 30-day sample of Cibinqo 100mg to take once a day and prescribed Loratadine 10mg to take twice a day. The Cibinqo has been effective, but the cost is prohibitive at $5,000 a month for 30 pills. The next option is Dupixent at $3,300 per month, also out of the question. I have tried taking the Cibinqo once every other day, but the rash returned with 2 -3 days. At this time, I have not been offered an affordable treatment option and I do not know what the resolution will be. Pfizer apparently caused this issue and now they want to charge me $60,000 a year to treat it.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Rash pruritic
- Hospital-Tage
- -
- Labordaten
- Dr took a skin sample for testing, and it was confirmed to be a form of dermatitis, which he reiterated was a reaction to the booster.
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- Famotadine 20MG, Ibuprophen, vitamin C
- Allergien
- Tetracycline sensitivity
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 63,0
- Geschlecht
- F
- Eingang
- 30.09.2022
- Impfdatum
- 01.03.2021
- Beginn
- 01.08.2022
- Tage bis Beginn
- 518,0
- Dosis
- 3
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Dizziness
Loss of personal independence in daily activities
Nausea
Oropharyngeal pain
Pain
Productive cough
Pyrexia
Respiratory tract congestion
Symptomtext
On about August 1, 2022 I developed a sore throat, all over body aches, some congestion and a low grade fever which progressed over the day. Most of the UR symptoms were similar to allergy symptoms. The symptoms worsened over the next few days with body aches that impaired ADLs, some dizziness and nausea. It took approximately 7 days for the symptoms to abate, although the congestion and productive cough lingered for another 7-10 days.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dizziness
- Hospital-Tage
- -
- Labordaten
- no labs. my doctor gave me a z pack as prophylactic measure against pneumonia .
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- type 2 diabetes well controlled
- Andere Medikamente
- levothyroxine, losartan potassium/hztz, victoza
- Allergien
- sulfa
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 47,0
- Geschlecht
- F
- Eingang
- 17.08.2022
- Impfdatum
- 30.11.2021
- Beginn
- 17.08.2022
- Tage bis Beginn
- 260,0
- Dosis
- 3
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: ja
COVID-19
Cough
Headache
Myalgia
Oropharyngeal pain
Pain
SARS-CoV-2 test positive
Sickle cell anaemia with crisis
Symptomtext
Discharge Provider: Private MD Primary Care Provider at Discharge: Private MD Admission Date: 8/10/2022 Discharge Date: 8/14/2022 PRESENTING PROBLEM: Sickle cell crisis (HCC) [D57.00]; COVID-19 [U07.1]; Sickle cell pain crisis (HCC) [D57.00]. HOSPITAL COURSE: The patient is a 47-year-old female with a history sickle cell disease as well as chronic pain syndrome which is narcotic dependent, history of DVT/PE on anticoagulation with Pradaxa as well as depression and anxiety, who presented with an acute sickle cell pain crisis on 08/10/2022. Patient also had noted a sore throat, with headache, cough and myalgias beginning on 08/08 with a home COVID test being positive on 08/09. At the time of admission, the patient was without hypoxia. Given her symptoms she was not a candidate for remdesivir or dexamethasone. Patient was admitted to the hospital service for further treatment of for COVID infection and sickle cell pain crisis. During the patient's hospitalization her hemoglobin remained stable, without any need for transfusion. Patient was treated with half-normal saline. Patient was continued on her home dose of Hydrea as well as Oxbryta. Patient was also continued on her home regimen MSIR, fentanyl patch, Neurontin, Elavil and Flexeril. IV Dilaudid was added to regimen at a dose of 2-3 mg every 2 hours. Patient's COVID infection was treated symptomatically with Tessalon Perles, Mucinex, and guaifenesin. With supportive care the patient's cough and sore throat improved. Patient's sickle cell pain crisis also improved, with pain returning to a tolerable level. As patient was clinically stable, she was discharged to home on 08/14/2022.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Headache
- Hospital-Tage
- 4,0
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Chronic, continuous use of opioids Severe episode of recurrent major depressive disorder, without psychotic features (HCC) Obesity Pseudotumor cerebri History of pulmonary embolus (PE) Gastroesophageal reflux disease without esophagitis Osteoarthritis of multiple joints Osteonecrosis (HCC) with bony infarct of both knees Irregular menstrual cycle Hb-SS disease without crisis (HCC) Unresolved grief Generalized anxiety disorder Insomnia Chronic anticoagulation SIRS (systemic inflammatory response syndrome) (HCC) Multiple comorbid conditions Counseling regarding advanced care planning and goals of care Personality disorder (HCC)
- Andere Medikamente
- ALPRAZolam (XANAX) 0.25 MG tablet amitriptyline (ELAVIL) 50 MG tablet benzonatate (TESSALON) 200 MG capsule busPIRone (BUSPAR) 30 MG tablet cyclobenzaprine (FLEXERIL) 10 MG tablet dabigatran etexilate mesylate (PRADAXA) 150 MG CAPS diphenhy
- Allergien
- MethadoneHallucinations BaclofenUnknown NafcillinDiarrhea, Nausea and Vomiting TopiramateUnknown
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 49,0
- Geschlecht
- F
- Eingang
- 28.06.2022
- Impfdatum
- 27.12.2021
- Beginn
- 18.06.2022
- Tage bis Beginn
- 173,0
- Dosis
- 3
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
Fatigue
Headache
Influenza like illness
Nausea
Pain
Respiratory tract congestion
SARS-CoV-2 test positive
Throat irritation
Symptomtext
I started with a scratchy throat on June 18, 2022. On June 19th I was not feeling much worse. On June 20th I was really tired, but I didn't think much of it. That evening I felt kind of nauseas and really tired. When I got home I tested positive for covid. The next day it felt like I had a bad case of the flu. I had body aches and terrible headaches. That day on June 21st I had a telemed appointment with a nurse practitioner. She prescribed me paxlovid, prednisone, azithromycin, and benzonatate. I only took the paxlovid. I took the first dose of it that evening. The next day I was feeling a lot better. That weekend I was feeling pretty good. I have a little congestion still but not much. I am about 98% recovered.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Fatigue
- Hospital-Tage
- -
- Labordaten
- At-home Covid Test- positive (6/20/2022) PCR Covid Test- positive (6/21/2022)
- Aktuelle Erkrankungen
- I had a bad cold at the end of November 2021.
- Vorgeschichte
- none
- Andere Medikamente
- Probiotic, Vitamins
- Allergien
- Minocycline
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 76,0
- Geschlecht
- M
- Eingang
- 11.05.2022
- Impfdatum
- 02.11.2021
- Beginn
- 11.02.2022
- Tage bis Beginn
- 101,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19
Pain in extremity
SARS-CoV-2 test positive
Symptomtext
02/11/22 presents to ED for "Leg Pain". PMHx of "hypertension, CKD, A. fib"
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pain in extremity
- Hospital-Tage
- -
- Labordaten
- 02/11/22 SARS-CoV-2 (COVID-19) by NAA detected
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 36,0
- Geschlecht
- M
- Eingang
- 09.05.2022
- Impfdatum
- 05.11.2021
- Beginn
- 04.05.2022
- Tage bis Beginn
- 180,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
Cough
Fatigue
Headache
Respiratory tract congestion
Rhinorrhoea
SARS-CoV-2 test positive
Symptomtext
I started getting symptoms of a cough. The next day, I had heavy congestion, nasal discharge, headache, and fatigue. My blood pressure also went up to 140/100 even with medications. I contacted my doctor. I went to an urgent care drive thru test and I took a PCR and rapid COVID-19 test which indicated positive. These symptoms are still ongoing.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Fatigue
- Hospital-Tage
- -
- Labordaten
- COVID-19 test
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- HTN
- Andere Medikamente
- Metoprolol Testosterone Propionate
- Allergien
- Benzocaine
- Vorherige Impfungen
- 2nd dose Pfizer - flu like symptoms with fever of 101.
- Staat
- MO
- Alter
- 84,0
- Geschlecht
- M
- Eingang
- 25.04.2022
- Impfdatum
- 19.11.2021
- Beginn
- 21.04.2022
- Tage bis Beginn
- 153,0
- Dosis
- 3
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Cough
Headache
Laboratory test
Rhinorrhoea
Symptomtext
symptoms fo cough, headache and runny nose. symptoms started 4/18. tested on 4/21 and then admitted to hospital
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Headache
- Hospital-Tage
- 2,0
- Labordaten
- unknown
- Aktuelle Erkrankungen
- unknown
- Vorgeschichte
- diabetes high blood pressure
- Andere Medikamente
- unknown
- Allergien
- unknown
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 66,0
- Geschlecht
- F
- Eingang
- 28.03.2022
- Impfdatum
- 02.12.2021
- Beginn
- 12.01.2022
- Tage bis Beginn
- 41,0
- Dosis
- 3
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Abdominal pain upper
Back pain
COVID-19
Dysphagia
Headache
Myalgia
Oropharyngeal pain
Pharyngeal swelling
SARS-CoV-2 test positive
Symptomtext
I contracted COVID-19. Some of my symptoms included were a sore throat, difficulty swallowing due to swelling in my throat, headache, muscle aches, back pain, and stomach pain. I went to urgent care. I was prescribed several medications.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Abdominal pain upper
- Hospital-Tage
- -
- Labordaten
- I tested positive for COVID-19 on 03/07/2022.
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- Rheumatoid Arthritis; Sjogren's disease; Epstein Barr; Herpes; Thyroid disease
- Andere Medikamente
- None
- Allergien
- Lidocaine
- Vorherige Impfungen
- Pneumonia vaccine in 2021, a lot of pain and could not move my arm.
- Staat
- NJ
- Alter
- 37,0
- Geschlecht
- F
- Eingang
- 25.03.2022
- Impfdatum
- 09.11.2021
- Beginn
- 31.12.2021
- Tage bis Beginn
- 52,0
- Dosis
- 3
- Route/Site
- - / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
Drug ineffective
SARS-CoV-2 test
Hypoaesthesia
Lymphadenopathy
Pain in extremity
Symptomtext
Heavy pain and numbness on left hand - limp node swelling; Heavy pain and numbness on left hand - limp node swelling; Heavy pain and numbness on left hand - limp node swelling; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 37-year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 09Nov2021 (Lot number: 33026bd) at the age of 37 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "No" (unspecified if ongoing), notes: Known allergies: No, Other medical history: No. There were no concomitant medications. Vaccination history included: Bnt162b2 (Dose Number: 2, Batch/Lot No: Ew0151, Location of injection: Arm Left), administration date: 05Apr2021, when the patient was 36 years old, for COVID-19 Immunization; Bnt162b2 (Dose Number: 1, Batch/Lot No: Ep7534, Location of injection: Arm Right), administration date: 15Mar2021, when the patient was 36 years old, for COVID-19 Immunization. The following information was reported: PAIN IN EXTREMITY (non-serious), HYPOAESTHESIA (non-serious), LYMPHADENOPATHY (non-serious) all with onset 31Dec2021, outcome "not recovered" and all described as "Heavy pain and numbness on left hand - limp node swelling". The event "heavy pain and numbness on left hand - limp node swelling", "heavy pain and numbness on left hand - limp node swelling" and "heavy pain and numbness on left hand - limp node swelling" was evaluated at the physician office visit. Therapeutic measures were taken as a result of pain in extremity, hypoaesthesia, lymphadenopathy. Additional information: AE treatment included pain medicine. Facility type vaccine Pharmacy or Drug Store. No other vaccine in four weeks and no other medications in two weeks. No covid prior vaccination and was covid tested post vaccination was yes. No follow-up attempts are possible. No further information is expected.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pain in extremity
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: No, Comment: Known allergies: No Other medical history: No.
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 62,0
- Geschlecht
- F
- Eingang
- 05.03.2022
- Impfdatum
- 23.11.2021
- Beginn
- 24.11.2021
- Tage bis Beginn
- 1,0
- Dosis
- 3
- Route/Site
- - / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Body temperature
Chills
Feeling abnormal
Headache
Pyrexia
Symptomtext
Chills; had a fever; Headache; Overall, did not feel well at all; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 62-year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 23Nov2021 (Lot number: 33026BD) at the age of 62 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Migraine headaches" (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (First dose: 19Mar2021 , lot: Unknown, NDC: Unknown, Expiration: Unknown , Route of administration: left arm), administration date: 19Mar2021, when the patient was 61 years old, for COVID-19 immunization; Bnt162b2 (Second dose: 09Apr2021 , lot: Unknown, NDC: Unknown, Expiration: Unknown, route of administration: left arm), administration date: 09Apr2021, when the patient was 61 years old, for COVID-19 immunization. The following information was reported: CHILLS (non-serious) with onset 24Nov2021, outcome "recovered" (25Nov2021), described as "Chills"; PYREXIA (non-serious) with onset 24Nov2021, outcome "recovered" (25Nov2021), described as "had a fever"; HEADACHE (non-serious) with onset 24Nov2021, outcome "not recovered", described as "Headache"; FEELING ABNORMAL (non-serious) with onset 24Nov2021, outcome "unknown", described as "Overall, did not feel well at all". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of pyrexia. Additional information: The patient woke up in the early morning on 24Nov2021 with chills, had a fever and a headache. She overall, did not feel well at all. She had a temperature of 101.6 and took some Tylenol. The Tylenol did help with the fever. Throughout the day on 24Nov2021, she felt pretty unwell. No follow-up attempts are possible. No further information is expected.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chills
- Hospital-Tage
- -
- Labordaten
- Test Name: Body temperature; Result Unstructured Data: Test Result:101.6
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Migraine headache.
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- AZ
- Alter
- 37,0
- Geschlecht
- M
- Eingang
- 27.02.2022
- Impfdatum
- 11.11.2021
- Beginn
- 11.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- - / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: ja
ER: unbekannt
Erholt: nein
Arthralgia
Inappropriate schedule of product administration
Loss of personal independence in daily activities
Pain
Pain in extremity
COVID-19
Drug ineffective
SARS-CoV-2 test
Peripheral swelling
Symptomtext
my hands swelled exponentially and the pain increased greatly and has now progressed to my wrists and arms; my hands swelled exponentially and the pain increased greatly and has now progressed to my wrists and arms; my hands swelled exponentially and the pain increased greatly and has now progressed to my wrists and arms; my hands swelled exponentially and the pain increased greatly and has now progressed to my wrists and arms; It is really impacting my daily life.; Dose 1, Drug Start date: 21Aug2021/ Dose 2, Drug Start date: 11Nov2021; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 37 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 11Nov2021 14:45 (Lot number: 33026BD) at the age of 37 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Asthma" (unspecified if ongoing). Concomitant medication(s) included: ADVAIR HFA; ALBUTEROL SULFATE; OXYCODONE. Vaccination history included: Bnt162b2 (Previous dose product:COVID 19, Previous dose brand:Pfizer, Previous dose lot number: EW0183,, Prev dose administration date:21Aug2021 , Previous dose administration time: 16:00, Previous dose number:1, Previous dose vaccine location:Left arm), administration date: 21Aug2021, when the patient was 37 years old, for Covid-19 immunization, reaction(s): "joint pain", "moderate swelling in both hands". The following information was reported: PERIPHERAL SWELLING (disability), PAIN (disability), ARTHRALGIA (disability), PAIN IN EXTREMITY (disability) all with onset 12Nov2021, outcome "unknown" and all described as "my hands swelled exponentially and the pain increased greatly and has now progressed to my wrists and arms"; LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (disability) with onset 12Nov2021, outcome "unknown", described as "It is really impacting my daily life."; INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (non-serious) with onset 11Nov2021 14:45, outcome "unknown", described as "Dose 1, Drug Start date: 21Aug2021/ Dose 2, Drug Start date: 11Nov2021". The events "my hands swelled exponentially and the pain increased greatly and has now progressed to my wrists and arms", "my hands swelled exponentially and the pain increased greatly and has now progressed to my wrists and arms", "my hands swelled exponentially and the pain increased greatly and has now progressed to my wrists and arms" and "it is really impacting my daily life." were evaluated at the physician office visit. The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (27Dec2021) positive, notes: Nasal Swab Unknown (done at "PRIVACY"); (07Jan2022) positive, notes: Nasal Swab Unknown (done at Urgent care). Therapeutic measures were not taken as a result of peripheral swelling, pain, arthralgia, pain in extremity, loss of personal independence in daily activities. Clinical course: The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient had no known allergies. He had never experienced or deal with anything like this until he received the vaccines. No follow-up attempts are possible. No further information is expected.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Arthralgia
- Hospital-Tage
- -
- Labordaten
- Test Date: 20211227; Test Name: Covid test; Test Result: Positive ; Comments: Nasal Swab Unknown (done at "PRIVACY"); Test Date: 20220107; Test Name: Covid test; Test Result: Positive ; Comments: Nasal Swab Unknown (done at Urgent care)
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Asthma
- Andere Medikamente
- ADVAIR HFA; ALBUTEROL SULFATE; OXYCODONE
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 34,0
- Geschlecht
- M
- Eingang
- 11.02.2022
- Impfdatum
- 11.12.2021
- Beginn
- 12.12.2021
- Tage bis Beginn
- 1,0
- Dosis
- 3
- Route/Site
- - / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Back pain
Fatigue
Injection site pain
Lymphadenopathy
Pyrexia
Symptomtext
The next day I had injection sight pain, swollen lymph node, fatigue. The fever and back pain for two days. The swollen lymph lasted for 7.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Back pain
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- N/A
- Andere Medikamente
- Lisinopril; hydrochlorothiazide
- Allergien
- AlphaFold; tobacco product
- Vorherige Impfungen
- -
- Staat
- AL
- Alter
- 24,0
- Geschlecht
- M
- Eingang
- 25.01.2022
- Impfdatum
- 08.04.2021
- Beginn
- 09.05.2021
- Tage bis Beginn
- 31,0
- Dosis
- 3
- Route/Site
- SYR / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: unbekannt
Asthenia
Cough
Headache
Nausea
Oropharyngeal pain
Rhinorrhoea
Symptomtext
Weakness, nausea, headache, extreme coughing, runny nose, sore throat. Everything started a month after the vaccine.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Headache
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- NA
- Vorgeschichte
- NA
- Andere Medikamente
- Sertraline
- Allergien
- NA
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 50,0
- Geschlecht
- F
- Eingang
- 18.01.2022
- Impfdatum
- 30.11.2021
- Beginn
- 17.12.2021
- Tage bis Beginn
- 17,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Eye swelling
Hypersensitivity
Injection site bruising
Injection site erythema
Injection site pain
Injection site pruritus
Injection site swelling
Mouth swelling
Pruritus
Rash
Swelling face
Swollen tongue
Symptomtext
Site: Bruising at Injection Site-Severe, Site: Itching at Injection Site-Severe, Site: Pain at Injection Site-Severe, Site: Redness at Injection Site-Severe, Site: Swelling at Injection Site-Severe, Systemic: Allergic: Itch (specify: facial area, extremeties)-Severe, Systemic: Allergic: Itch Generalized-Severe, Systemic: Allergic: Rash Generalized-Severe, Systemic: Allergic: Swelling of Face / Eyes / Mouth / Tongue-Severe
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site bruising
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- AL
- Alter
- 79,0
- Geschlecht
- M
- Eingang
- 18.01.2022
- Impfdatum
- 31.01.2021
- Beginn
- 15.04.2021
- Tage bis Beginn
- 74,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: ja
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: ja
Abdominal operation
Abdominal pain
Blood test
Computerised tomogram abdomen abnormal
Gastrointestinal necrosis
Intestinal obstruction
Vomiting
Symptomtext
On the afternoon of April 15, I developed cramping abdominal pain that gradually increased over about two hours, at which time I started vomiting. I went to the emergency room, and after a more than three-hour wait received a CT scan that showed a closed-loop obstruction. At the emergency abdominal operation, I was found to have an 85 cm. loop of dead small intestine with no apparent mechanical or vascular cause. The affected bowel was removed. I recovered without complication, and I have had no further symptoms.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Abdominal pain
- Hospital-Tage
- 4,0
- Labordaten
- CT scan April 16 in Grandview ER; blood work associated with admission, operation, and recovery.
- Aktuelle Erkrankungen
- mild hypertension, lumbar radiculopathy, polymyalgia rheumatica
- Vorgeschichte
- mild hypertension, hypothyroidism (s/p total thyroidectomy for papillary carcinoma)
- Andere Medikamente
- prescriptions: levothyroxine, triamterene-hydrochlorothiazide, prednisone; tramadol OTC: acetaminophen, melatonin, vitamins
- Allergien
- Penicillin
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 39,0
- Geschlecht
- F
- Eingang
- 13.01.2022
- Impfdatum
- 07.01.2022
- Beginn
- 12.01.2022
- Tage bis Beginn
- 5,0
- Dosis
- 3
- Route/Site
- SYR / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Interchange of vaccine products
Rash
Urticaria
Symptomtext
Full body rashes and hives at day 5.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Rash
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- Cymbalta, Straterra, Iron supplement, vitamins.
- Allergien
- None
- Vorherige Impfungen
- Moderna vaccine, 2/9/21, lot 032L20A
- Staat
- NV
- Alter
- 59,0
- Geschlecht
- F
- Eingang
- 13.01.2022
- Impfdatum
- 11.11.2021
- Beginn
- 11.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- SYR / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Burning sensation
Hypoaesthesia
Immediate post-injection reaction
Incomplete course of vaccination
Laboratory test normal
Muscular weakness
Musculoskeletal stiffness
Nerve conduction studies
Pain in extremity
Symptomtext
Immediate sensation to right hand (stiffening). Few hours later, pain in that hand and top of middle finger burned for 3 weeks. Next few days, burning in feet, numbness in legs, more pain and weakness in both hands. 11/22/2021 saw an Internist and labs performed. 12/02/2021 saw a Neurologist. 12/13/2021 had nerve conduction test performed. Doctor advised second COVID-19 vaccine should not be administered since severe reaction occurred to my nerves. It is unknown at this time if issue will resolve on its own.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pain in extremity
- Hospital-Tage
- -
- Labordaten
- 11/22/2021 labs normal 12/13/2021 Nerve Conduction Test (no neuropathy)
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- Vit D3 B-Complex
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 13,0
- Geschlecht
- F
- Eingang
- 13.01.2022
- Impfdatum
- 12.01.2022
- Beginn
- 12.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Abdominal pain upper
Flushing
Pallor
Symptomtext
Pt received Adult Pfizer 0.3 ml via IM at 1530.pt reports feeling flushed and stomach pain.Facial color pallor noted and vitals below baseline noted. BP 74/34, Pulse 70, O2 98% Resp 18 . No SOB noted. Pt given fluids and tolerated well.Legs elevated and reported to physician.Pt awake and verbally responsive and transferred to Pediatric unit via wheelchair.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Abdominal pain upper
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- -
- Andere Medikamente
- none
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 35,0
- Geschlecht
- F
- Eingang
- 10.01.2022
- Impfdatum
- 09.12.2021
- Beginn
- 23.12.2021
- Tage bis Beginn
- 14,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Axillary pain
Injection site pain
Lymphadenopathy
Lymphoedema
Mastitis
Maternal exposure during breast feeding
Swelling
Symptomtext
I had significant lymphadenopathy and lymphedema of the left axillary space starting about 24 hours after vaccination as well as significant arm pain at injection site and in my axillary space. The swelling lasted over a week, and there were prominent, palpable lymph nodes for at least a week or longer. The visible lymphadenopathy/lymphedema resolved after about a week and a half, but I developed mastitis of the left breast on 12/23-12/24. I am breastfeeding, and I have been since 2/1/2021. This is my third child to breastfeed, and I have never developed mastitis before. Since the affected breast was on the same side as the lymphadenopathy/lymphedema, I felt it possible that the vaccination and ADR may have contributed to my development of this breastfeeding complication.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Axillary pain
- Hospital-Tage
- -
- Labordaten
- None; Prescribed cephalexin 500 mg PO BID x 10 days which resolved the condition. I called my OB/Gyn on call when symptoms developed and received treatment from that consultation.
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- MD
- Alter
- 57,0
- Geschlecht
- F
- Eingang
- 29.12.2021
- Impfdatum
- 07.11.2021
- Beginn
- 11.11.2021
- Tage bis Beginn
- 4,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: ja
Cellulitis
Injection site bruising
Injection site erythema
Injection site pain
Vaccination site rash
Symptomtext
Site: Bruising at Injection Site-Severe, Site: Pain at Injection Site-Severe, Site: Redness at Injection Site-Severe, Additional Details: Patient states after receiving vaccine she noticed rash around the vaccine site shortly after. She then reported to the hospital, where she was diagnosed and treated for cellulitis.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site bruising
- Hospital-Tage
- 3,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CT
- Alter
- 53,0
- Geschlecht
- F
- Eingang
- 23.12.2021
- Impfdatum
- 24.11.2021
- Beginn
- 24.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- - / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Fatigue
Headache
Immunisation
Vaccination site pain
Symptomtext
headache; Fatigue; injection site pain; Dose Number: 3; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 53 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 24Nov2021 10:30 (Lot number: 33026bd) at the age of 53 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "migraines" (unspecified if ongoing); "latex" (unspecified if ongoing); "pcn" (unspecified if ongoing). Concomitant medication(s) included: GABAPENTIN; OMEPRAZOLE; MELATONIN; ZYRTEC [CETIRIZINE HYDROCHLORIDE]. Past drug history included: Neomyocin, reaction(s): "known allergies: neomyocin". Vaccination history included: Bnt162b2 (Dose Number: 2, Batch/Lot No: ep6955, Location of injection: Arm Left), administration date: 02Apr2021, when the patient was 52 years old, for Covid-19 immunization; Bnt162b2 (Dose Number: 1, Batch/Lot No: EL3247, Location of injection: Arm Left), administration date: 12Mar2021, when the patient was 52 years old, for Covid-19 immunization. The following information was reported: IMMUNISATION (non-serious) with onset 24Nov2021 10:30, outcome "unknown", described as "Dose Number: 3"; HEADACHE (non-serious) with onset 25Nov2021 17:00, outcome "recovered" (2021), described as "headache"; FATIGUE (non-serious) with onset 25Nov2021 17:00, outcome "recovered" (2021), described as "Fatigue"; VACCINATION SITE PAIN (non-serious) with onset 25Nov2021 17:00, outcome "recovered" (2021), described as "injection site pain". Therapeutic measures were taken as a result of headache, fatigue, vaccination site pain. No follow-up attempts are possible. No further information is expected.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Fatigue
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Latex allergy; Migraine; Nephrostomy
- Andere Medikamente
- GABAPENTIN; OMEPRAZOLE; MELATONIN; ZYRTEC [CETIRIZINE HYDROCHLORIDE]
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- UT
- Alter
- 69,0
- Geschlecht
- F
- Eingang
- 20.12.2021
- Impfdatum
- 14.12.2021
- Beginn
- 19.12.2021
- Tage bis Beginn
- 5,0
- Dosis
- 3
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Erythema
Rash macular
Symptomtext
L lateral breast with redness, blotchy macular rash w/o pain or pruritis
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Rash macular
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- h/o fibromyalgia, not worse in last month
- Andere Medikamente
- Armour thyroid 120mg daily, compounded hormone replacement cream (unknown which hormones)
- Allergien
- Aspirin, tetracycline, wool, grass
- Vorherige Impfungen
- -
- Staat
- CT
- Alter
- 18,0
- Geschlecht
- M
- Eingang
- 10.12.2021
- Impfdatum
- 24.11.2021
- Beginn
- 24.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- - / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Immunisation
Lymphadenopathy
Pyrexia
Symptomtext
swollen lymph nodes in arm pit; low grade fever (101F); Booster shot; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. An 18-year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 24Nov2021 10:00 (Lot number: 33026bd) at the age of 18 years as dose 3 (booster), single for covid-19 immunization; influenza vaccine (FLU VACCINE VII), administered in arm right, administration date 24Nov2021 (Batch/Lot number: unknown) as unk unk, single. The patient's relevant medical history and concomitant medications were not reported. Past drug history included: Ibuprofen, reaction(s): "Allergy", notes: known allergies: ibuprofen. Vaccination history included: Bnt162b2 (Dose Number: 2, Batch/Lot No: ep6955, Location of injection: Arm Left), administration date: 17Apr2021, when the patient was 17 years old, for Covid-19 immunization; Bnt162b2 (Dose Number: 1, Batch/Lot No: ep6955), administration date: 27Mar2021, when the patient was 17 years old, for Covid-19 immunization. The following information was reported: IMMUNISATION (non-serious) with onset 24Nov2021 10:00, outcome "unknown", described as "Booster shot"; LYMPHADENOPATHY (non-serious) with onset 25Nov2021, outcome "recovering", described as "swollen lymph nodes in arm pit"; PYREXIA (non-serious) with onset 25Nov2021, outcome "recovering", described as "low grade fever (101F)". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of lymphadenopathy, pyrexia.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pyrexia
- Hospital-Tage
- -
- Labordaten
- Test Name: low grade fever (101F); Result Unstructured Data: Test Result:low grade fever (101F) Fahrenheit
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- UT
- Alter
- 58,0
- Geschlecht
- M
- Eingang
- 07.12.2021
- Impfdatum
- 06.12.2021
- Beginn
- 06.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Immunisation
Incorrect dose administered
Pain in extremity
Symptomtext
Client is a 58 year old man who came in to receive his Pfizer booster dose. Vaccinator administered a Pfizer pediatric (5-11) year old dose. Vaccinator then noticed the mistake and Client was revaccinated with the Pfizer 12+ dose. Client reports waking up with a sore left arm. Client denies having other symptoms
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pain in extremity
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- unknown
- Vorgeschichte
- unknown
- Andere Medikamente
- unknown
- Allergien
- unknown
- Vorherige Impfungen
- -
- Staat
- MD
- Alter
- 42,0
- Geschlecht
- F
- Eingang
- 07.12.2021
- Impfdatum
- 07.11.2021
- Beginn
- 01.11.2021
- Tage bis Beginn
- -
- Dosis
- 1
- Route/Site
- - / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Vaccination site erythema
Vaccination site induration
Vaccination site pruritus
Vaccination site swelling
Symptomtext
Redness, in a circular pattern around injection site, measuring 3 inches by 2.5 inches.; Swelling, in a circular pattern around injection site, measuring 3 inches by 2.5 inches.; Itching, in a circular pattern around injection site, measuring 3 inches by 2.5 inches.; Indurated, in a circular pattern around injection site, measuring 3 inches by 2.5 inches.; This is a spontaneous report received from a contactable reporter (consumer). The reporter is the patient. A 42-year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in left arm, administration date 07Nov2021 at 14:00 (Lot number: 33026BD) at the age of 42 years as dose 1, single for COVID-19 immunisation and the patient also received bnt162b2 (BNT162B2), administered in right arm, administration date 28Nov2021 at 14:00 (Lot number: FH8027) at the age of 42 years as dose 2, single for COVID-19 immunisation. The patient's relevant medical history included: "Hypothyroidism" (unspecified if ongoing). Concomitant medications were not reported. The following information was reported: VACCINATION SITE ERYTHEMA (non-serious), VACCINATION SITE SWELLING (non-serious), VACCINATION SITE PRURITUS (non-serious) and VACCINATION SITE INDURATION (non-serious), all with onset unknown date in Nov2021, outcome "unknown" and all described as "redness, swelling, itching and indurated in a circular pattern around the injection site, measuring 3 inches by 2.5 inches". It was unknown if therapeutic measures were taken as a result of vaccination site erythema, vaccination site swelling, vaccination site pruritus and vaccination site induration. Additional Information: Reaction began 72 post injection. There was no drainage and no streaking with pain even with light pressure. The patient had no known allergies. The patient did not receive any other vaccines within four weeks prior to COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Vaccination site pruritus
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Hypothyroidism
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 58,0
- Geschlecht
- F
- Eingang
- 04.12.2021
- Impfdatum
- 27.11.2021
- Beginn
- 27.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Body temperature
Chills
Headache
Immunisation
Pyrexia
Symptomtext
Chills; Fever 101.2; Headache; Dose received 3; This is a spontaneous report from a non-contactable reporter (consumer). The reporter is the patient. A 58 year-old female patient (not pregnant) received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), administration date 27Nov2021 at 16:00 (Batch/Lot number: 33026BD) at the age of 58 years as dose 3 (booster), single for COVID-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: FLU, start date: 13Nov2021 for immunisation and unspecified cholesterol lowering medicine and vitamins. Past drug history included: Codeine, reaction(s): "Drug allergy" and Tetracycline, reaction(s): "Drug allergy". Vaccination history included: BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, DOSE 1, SINGLE, Lot number: UNKNOWN, Route of administration: Unspecified), administration date: on an unknown date in Feb2021, when the patient was 57 years old, for COVID-19 immunisation and BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, DOSE 2, SINGLE Lot number: UNKNOWN, Route of administration: Unspecified), administration date: on an unknown date in Mar2021, when the patient was 57 years old, for COVID-19 immunisation. The following information was reported: CHILLS (non-serious), PYREXIA (non-serious), HEADACHE (non-serious) all with onset 28Nov2021 at 16:00, outcome "recovering" and described as ''chills, fever 101.2 and headache''. Therapeutic measures were not taken as a result of chills, pyrexia and headache. Relevant laboratory tests and procedures are available in the appropriate section. Additional Information: The patient received other vaccines within four weeks prior to COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No follow-up attempts are possible. No further information is expected.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chills
- Hospital-Tage
- -
- Labordaten
- Test Date: 20211128; Test Name: Body temperature; Result Unstructured Data: Test Result:101.2; Comments: At 16:00
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 62,0
- Geschlecht
- F
- Eingang
- 03.12.2021
- Impfdatum
- 28.11.2021
- Beginn
- 29.11.2021
- Tage bis Beginn
- 1,0
- Dosis
- 3
- Route/Site
- - / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Confusional state
Diarrhoea
Fatigue
Joint swelling
Symptomtext
Severe diarrhea, exhaustion, swollen ankles and confusion.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Diarrhoea
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Leukocytosis, back problems
- Andere Medikamente
- Hydrocodone, Alprazolam, Cyclobenzaprine, Duloxetine, Vitamin D, Multivitamin, stool softener
- Allergien
- Shellfish, fish, avocado, penicillin
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- 74,0
- Geschlecht
- F
- Eingang
- 01.12.2021
- Impfdatum
- 12.11.2021
- Beginn
- 13.11.2021
- Tage bis Beginn
- 1,0
- Dosis
- 3
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Computerised tomogram head
Computerised tomogram neck
Echocardiogram
Electrocardiogram
Electrocardiogram ambulatory
Fatigue
Headache
Myalgia
Nausea
Transient ischaemic attack
Symptomtext
On day after vaccine I experienced fatigue, nausea, headache, and myalgia. On the 9th day after Vaccine. I was taken by ambulance, evaluated in ER and admitted for four days.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Fatigue
- Hospital-Tage
- -
- Labordaten
- I was given an EKG, echo cardio gram, CT of head and neck, neuro testing every few hours as well as vitals. I was placed in a heart monitor, and given aspirin and plavix.
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Hypothyroidism
- Andere Medikamente
- Levoxyl: omneprozole; atorvastastatin; atenolol; melatonin;
- Allergien
- Demerol
- Vorherige Impfungen
- Pfizer Covid 19
- Staat
- UT
- Alter
- 29,0
- Geschlecht
- F
- Eingang
- 01.12.2021
- Impfdatum
- 30.11.2021
- Beginn
- 30.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Urticaria
Symptomtext
Client was scheduled and wanted her Moderna booster, as her first series was moderna. Client states that she got hives on her stomach, but they went away, and she thinks they might be associated with vaccine.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Urticaria
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- no
- Vorgeschichte
- asthma
- Andere Medikamente
- asthma inhaler
- Allergien
- hay fever, pollen
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 70,0
- Geschlecht
- M
- Eingang
- 29.11.2021
- Impfdatum
- 23.11.2021
- Beginn
- 23.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Pain in extremity
Symptomtext
Patient came into the pharamcy today and stated that even after 6 days of getting the vaccine thier arm still hurts(left arm). He said he did some research and was corncerned about SIRVA but he stated no mobliity issues or any other sort of movement issues. He showed me the picture of his arm where the bandaid was and it looked like in the right area of deltoid. He said he was just concerned about the pain becuase this is his Booster shot and he did not feel this way for the first 2 shots. Advised him to see a MD to address his concern and we will also follow up with him as to how his pain is doing.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pain in extremity
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TN
- Alter
- 63,0
- Geschlecht
- F
- Eingang
- 27.11.2021
- Impfdatum
- 18.11.2021
- Beginn
- 18.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- - / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Immunisation
Vaccination site erythema
Vaccination site pain
Vaccination site pruritus
Vaccination site swelling
Vaccination site warmth
Symptomtext
Red, swollen, warm to the touch injection site; Red, swollen, warm to the touch injection site; Red, swollen, warm to the touch injection site; Injection site with pain and itching; Injection site with pain and itching; Administration date 18Nov2021; dose received =3; This is a spontaneous report from a contactable nurse. A 63-year-old non-pregnant female patient received third (booster) dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 33026BD) via an unspecified route of administration in the right arm on 18Nov2021 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. Medical history included clotting disorder and hypertension. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient received unspecified concomitant medications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: GN6197) via an unspecified route of administration in the right arm on an unknown date in 08Mar2021 (at the age of 62-years-old) and also received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the left arm on an unknown date in 2021 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. The patient previously took butorphanol tartrate (STADOL) and erythromycin (MANUFACTURER UNKNOWN) and experienced drug allergy. On 21Nov2021, the patient experienced red, swollen, warm to the touch, injection site with pain and itching. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of the events red, swollen, warm to the touch, injection site with pain and itching which included treatment with unspecified antihistamines, paracetamol (TYLENOL) and ibuprofen (MANUFACTURER UNKNOWN) on an unknown date in 2021. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events red, swollen, warm to the touch injection site and injection site with pain and itching was recovering at the time of this report.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Vaccination site pain
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Clotting disorder; Hypertension
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 37,0
- Geschlecht
- F
- Eingang
- 25.11.2021
- Impfdatum
- 24.11.2021
- Beginn
- 24.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Dysgeusia
Hypoaesthesia oral
Immediate post-injection reaction
Throat irritation
Urticaria
Symptomtext
Tasted metal immediately. Within 4 minutes I felt burning in throat and got very itchy. My throat started itching, I got hives all over my body. Lips went numb.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Urticaria
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- Lisinopril, Penicillin, Bees, Tahini, Fentanyl
- Vorherige Impfungen
- Dpt
- Staat
- HI
- Alter
- 51,0
- Geschlecht
- M
- Eingang
- 24.11.2021
- Impfdatum
- 23.11.2021
- Beginn
- 23.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Abdominal pain upper
Fatigue
Pain
Pain in extremity
Symptomtext
Soreness in arm within 1 hour; fatigue and body aches within 5 hours and persisting at 20 hours; stomach cramps at 12 hours until 18 hours; stomach cramps and body aches diminished with 400mg of ibuprofen at 5 hours, 13 hours, and 18 hours.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Abdominal pain upper
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- Escitalopram, Tadalifil
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 54,0
- Geschlecht
- M
- Eingang
- 24.11.2021
- Impfdatum
- 23.11.2021
- Beginn
- 23.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Arthralgia
Body temperature increased
Chest discomfort
Fatigue
Headache
Symptomtext
2 hours after shot, joint pain increased 10 fold. I became exhausted, headache temp of 101. Started to get tight in chest. Felt the same as when I started with COVID in Oct of 2020
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Arthralgia
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Diverticulitis
- Vorgeschichte
- Asthma, Diverticulosis, Arthritis
- Andere Medikamente
- B6, D3, C, Magnesium, Potassium, Singulair, Advair, Nexium, Voltaren, Glucosamine, Chondriotin, Cialis, Xyzal, Billberry, Lutein, Augmentin, Bio"T" Testosterone implants, Iron
- Allergien
- Breathine, Morphine, Flexiril
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 54,0
- Geschlecht
- F
- Eingang
- 23.11.2021
- Impfdatum
- 10.11.2021
- Beginn
- 10.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- - / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Axillary pain
Breast pain
Breast swelling
Chills
Dizziness
Fatigue
Immunisation
Myalgia
Pain in extremity
Peripheral coldness
Swelling
Symptomtext
Sore arm; Fatigue; Light headed within 6 h; Cold hands; Mild chill 12h after injection severe chill started 18h after injection & lasted about 5 hours; Muscle aches; Sore and swelling armpit and breast same site as the injection site; Sore and swelling armpit and breast same site as the injection site; Sore and swelling armpit and breast same site as the injection site; Sore and swelling armpit and breast same site as the injection site; The patient received the third/booster dose of BNT162b2; This is a spontaneous report from a non-contactable consumer, the patient. A 54-year-old non-pregnant female patient received the third dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 33026BD) via an unspecified route of administration in left arm on 10Nov2021 at 19:00 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. Medical history included perimenopause. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included estradiol (MANUFACTURER UNKNOWN) and norethisterone acetate (NORETHINDRONE ACETATE); both for unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3248) via an unspecified route of administration in the left arm on 03Mar2021 (at the age of 53-years-old) and second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 24Mar2021 (at the age of 53-years-old) as a single dose for COVID-19 immunisation. On 11Nov2021, the patient experienced sore arm, fatigue, light headed within 6 hours, cold hands and mild chill approximately 12 hours after injection, muscle aches and severe chill started approximately 18h after injection & lasted approximately 5 hours, sore & swelling armpit and breast same site as the injection arm started approximately 18h after injection and persist at the time of submitting this report. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of the events. The clinical outcome of the event mild chill approximately 12hours after injection, severe chill started approximately 18h after injection & lasted approximately 5 hours was resolved on 11Nov2021 and sore arm, fatigue, light headed within 6 hours, cold hands, muscle aches, sore & swelling armpit and breast same site as the injection arm started approximately 18h after injection was resolving at the time of this report. No follow-up attempts are possible. No further information is expected.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Axillary pain
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Perimenopause.
- Andere Medikamente
- ESTRADIOL; NORETHINDRONE ACETATE.
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 11,0
- Geschlecht
- M
- Eingang
- 22.11.2021
- Impfdatum
- 22.11.2021
- Beginn
- 22.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Incorrect dose administered
Pain in extremity
Symptomtext
Patient is only 11 years old and received 0.3ml, which is for ages 12+. Upon noticing the mistake, we contacted the patient's father. He said that child is feeling fine, and just has a sore arm.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pain in extremity
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 32,0
- Geschlecht
- F
- Eingang
- 22.11.2021
- Impfdatum
- 20.11.2021
- Beginn
- 20.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Hypoaesthesia
Hypoaesthesia oral
Nausea
Symptomtext
Approx. 20 minutes after shot administered, patient began to have symptoms of numbness along nose and mouth. Had no dyspena or chest pain. No hives. had nausea but no vomiting. O2 sat was 99%, BP 100/60, chest is clear Benadryl 25mg was given in the Right arm. Patient was monitored for 30 minutes. Symptoms did improve and her exam was unremarkable. She was able to go home with no difficulties.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Nausea
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NC
- Alter
- 52,0
- Geschlecht
- F
- Eingang
- 19.11.2021
- Impfdatum
- 09.11.2021
- Beginn
- 09.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- - / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Abdominal pain upper
Headache
Lymphadenopathy
Myalgia
Pain
Body temperature
Limb discomfort
Nausea
Pyrexia
Swelling
Pain in extremity
Vomiting
Symptomtext
This is a spontaneous report from a contactable consumer, the patient. A 52-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 33026BD) via an unspecified route of administration in the left arm on 09Nov2021 at 10:30 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. The patient was allergic to sulpha meds and cephalosporins. Prior to vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included VITAMIN C for an unspecified indication from an unknown date and unknown if ongoing. The patient previously received ASPIRIN and experienced drug allergy. On 09Nov2021 at 15:00, the patient experienced discomfort in the left arm and swollen feeling in the armpit. On 09Nov2021 at 20:00, the patient experienced 101.5 fever and swollen lymph nodes underneath left arm. On 10Nov2021, the patient experienced 103.5 fever, lymph nodes very swollen, muscle ache, headache, and nausea. On 11Nov2021, the patient experienced fever 101.5, lymph nodes very swollen, headache, nausea, and body aches. On 12Nov2021, the patient did not have fever but the lymph nodes were swollen and had headache. On 13Nov2021 and 14Nov2021, the patient experienced lymph node swollen and on 15Nov2021, the lymph nodes were still swollen. The events resulted in doctor or other healthcare professional office/clinic visit. No therapeutic measures were taken as a result of the events. On 09Nov2021, 10Nov2021, and 11Nov2021, the patient underwent body temperature tests and the result was 101.5 (unspecified units), 103.5 (unspecified units), and 101.5 (unspecified units) respectively. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fever was resolved on 12Nov2021, discomfort in the left arm and swollen feeling in the armpit, swollen lymph nodes underneath left arm, swollen lymph nodes, lymph nodes were still swollen, headache, nausea, ache, and muscle ache were not resolved at the time of this report.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Abdominal pain upper
- Hospital-Tage
- -
- Labordaten
- Test Date: 20211111; Test Name: Body temperature; Result Unstructured Data: Test Result: 101.5; Comments: fever 101.5; Test Date: 20211110; Test Name: Body temperature; Result Unstructured Data: Test Result: 103.5; Comments: fever 103.5; Test Date: 20211109; Test Name: Body temperature; Result Unstructured Data: Test Result: 101.5; Comments: At 20:00, 101.5 fever.
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Allergic reaction to antibiotic Cephalosporins; COVID-19; Sulfonamide allergy
- Andere Medikamente
- VITAMIN C
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 61,0
- Geschlecht
- F
- Eingang
- 17.11.2021
- Impfdatum
- 12.11.2021
- Beginn
- 12.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Chills
Cough
Diarrhoea
Fatigue
Headache
Influenza like illness
Influenza virus test negative
Myalgia
Nausea
Paranasal sinus discomfort
Pyrexia
SARS-CoV-2 test negative
Vomiting
Symptomtext
Pt. states that after receiving the 3rd Booster of Phizer 11/12/2021, started experiencing symptoms that evening of loose stool, vomiting, fatigue, headache, muscle ache, sinus pressure, chills, slight cough, fever (100.5), flu-like symptoms, and nausea. 11/14/2021 tested for Covid-19 = Negative, Flu Test = Negative. No noted Primary visit/communications. Still continuing to experience symptoms.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chills
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- N/A
- Andere Medikamente
- Fluzone, Cranberry, Calcium, Vitamin D, Vitamin E, Cingular, Valise clover
- Allergien
- Tianlong
- Vorherige Impfungen
- 2020 Influenza Vaccine (Quarantined Covid-19=Negative, Flu-Like Symptoms lasting 2 weeks)
- Staat
- MO
- Alter
- 5,0
- Geschlecht
- M
- Eingang
- 15.11.2021
- Impfdatum
- 14.11.2021
- Beginn
- 15.11.2021
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Arthralgia
Pain in extremity
Product administered to patient of inappropriate age
Symptomtext
child should have gotten the pediatric dose, but the 12+ formulation was used but diluted and administered with the pediatric guidelines (1.3ml diluent and 0.2ml dose). mom reports child complaining of sore arm and achy joints.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Arthralgia
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 39,0
- Geschlecht
- F
- Eingang
- 14.11.2021
- Impfdatum
- 12.11.2021
- Beginn
- 14.11.2021
- Tage bis Beginn
- 2,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Lymphadenopathy
Pain
Symptomtext
Supraclavicular lymph node - swelling, pain - left side (same side vaccine was administered)
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pain
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Hashimoto?s Thyroiditis
- Andere Medikamente
- Synthroid, multivitamin, vitamin D, B complex vitamin
- Allergien
- Erythromycin base
- Vorherige Impfungen
- -
- Staat
- NE
- Alter
- 31,0
- Geschlecht
- F
- Eingang
- 05.11.2021
- Impfdatum
- 03.11.2021
- Beginn
- 05.11.2021
- Tage bis Beginn
- 2,0
- Dosis
- 1
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Abdominal pain upper
Fatigue
Nausea
Rash
Rash pruritic
Sleep disorder
Symptomtext
Day One of vaccine, felt very fatigued Day Two after vaccine had stomach ache, lots of nausea Day Three of vaccine, was awakened at 0630 with itchy, bumpy rash on lower back. Called her PCP and was advised to take Benadryl and call the health department to report incident. Took 2nd dose of Allegra D and started to feel better. Took 50mg dose of Benadryl before ending phone call. Provided with direct line to contact on call nurse at health department to report progress over the weekend and to see her doctor on Monday if no improvement or to ER if symptoms worsen.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Abdominal pain upper
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Sinusitis
- Vorgeschichte
- Environmental allergies
- Andere Medikamente
- Allegra D daily. Today at 0800, took last dose of doxycycline 100mg BID she started 10/28/21 for sinus infection.
- Allergien
- PCN
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 63,0
- Geschlecht
- F
- Eingang
- 17.08.2023
- Impfdatum
- 28.11.2021
- Beginn
- 01.02.2023
- Tage bis Beginn
- 430,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Hypersensitivity
Symptomtext
ALLERGIC REACTION, INIT
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Hypersensitivity
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 76,0
- Geschlecht
- M
- Eingang
- 27.06.2023
- Impfdatum
- 27.01.2021
- Beginn
- 17.03.2022
- Tage bis Beginn
- 414,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Angina pectoris
Angina unstable
Blood creatinine
Blood glucose normal
Blood potassium normal
Blood sodium normal
Glomerular filtration rate normal
Percutaneous coronary intervention
Symptomtext
Reported Symptoms: 10002391:ANGINAL PAIN; Narrative: Pt reported unstable angina eventually requiring PCI approximately 3 months after 3rd dose of Pfizer Covid vaccine Other Relevant HX: No tobacco use
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Angina pectoris
- Hospital-Tage
- -
- Labordaten
- N 139, K 4.5, SCr 0.9, eGFR 85, Glu 93 (3/17/2022)
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 68,0
- Geschlecht
- M
- Eingang
- 30.03.2023
- Impfdatum
- 05.11.2021
- Beginn
- 17.01.2023
- Tage bis Beginn
- 438,0
- Dosis
- 3
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19
SARS-CoV-2 test positive
Vaccine breakthrough infection
Symptomtext
Breakthrough case admission after 3 vaccines Pfizer 4/1/21 Lot# Ew8734; Pfizer 4/19/21 Lot# Ew0165; Pfizer 11/5/21 Lot# 33026BD LOT NUMBER IS FROM DATABASE
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19
- Hospital-Tage
- -
- Labordaten
- covid +
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 61,0
- Geschlecht
- M
- Eingang
- 28.03.2023
- Impfdatum
- 17.11.2021
- Beginn
- 22.05.2022
- Tage bis Beginn
- 186,0
- Dosis
- 2
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19
SARS-CoV-2 test positive
Vaccine breakthrough infection
Symptomtext
Breakthrough case admission after 2 vaccines Pfizer 3/11/21 Lot# EN6199; Pfizer 11/17/21 LOt# 33026BD
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19
- Hospital-Tage
- -
- Labordaten
- COVID +
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- AL
- Alter
- 56,0
- Geschlecht
- M
- Eingang
- 23.02.2023
- Impfdatum
- 30.11.2021
- Beginn
- 21.07.2022
- Tage bis Beginn
- 233,0
- Dosis
- 3
- Route/Site
- - / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
Drug ineffective
Interchange of vaccine products
SARS-CoV-2 test
Symptomtext
Treatment of COVID-19; Treatment of COVID-19; Pfizer Dose 3 30Nov2021, Moderna Dose 4 21Jul2022; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 58-year-old male patient received BNT162b2 (BNT162B2), on 21Mar2021 as dose 1, single (Lot number: ER8730), in left arm, on 19Apr2021 as dose 2, single (Lot number: FL3302), in left arm and on 30Nov2021 as dose 3 (booster), single (Lot number: 33026BD) at the age of 56 years, in left arm for covid-19 immunisation; elasomeran (MODERNA COVID-19 VACCINE), on 21Jul2022 as dose 4 (booster), single (Lot number: 060A22A), in left arm for covid-19 immunisation. The patient's relevant medical history included: "known allergies: Penicillin" (unspecified if ongoing). There were no concomitant medications. The following information was reported: INTERCHANGE OF VACCINE PRODUCTS (medically significant) with onset 21Jul2022, outcome "unknown", described as "Pfizer Dose 3 30Nov2021, Moderna Dose 4 21Jul2022"; DRUG INEFFECTIVE (medically significant), outcome "unknown", COVID-19 (medically significant), outcome "not recovered" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19
- Hospital-Tage
- -
- Labordaten
- Test Name: Home test; Test Result: Positive
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Penicillin allergy
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 57,0
- Geschlecht
- F
- Eingang
- 04.01.2023
- Impfdatum
- 14.09.2022
- Beginn
- 26.12.2022
- Tage bis Beginn
- 103,0
- Dosis
- 3
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19
Mental status changes
SARS-CoV-2 test positive
Symptomtext
Hospitalization: 12/26/2022 - 1/3/2023 (8 days) Presentation to the ED: AMS. COVID + date: 12/26/2022 Treatment: steroids. Discharge to: home. Pfizer ER8733 3/29/2021 Pfizer EW0161 4/19/2021 Pfizer 33026BD 11/19/2021 Pfizer FM9992 5/1/2022 Pfizer Bivalent GJ2524 9/14/2022
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- breast cancer, hyperparathyroidism, morbid obesity.
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 60,0
- Geschlecht
- M
- Eingang
- 20.12.2022
- Impfdatum
- 15.12.2021
- Beginn
- 21.12.2021
- Tage bis Beginn
- 6,0
- Dosis
- 3
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Tinnitus
Symptomtext
Ringing in ears, both. Tinnitus. Came on like a light switch a few days after Booster Vaccine
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Tinnitus
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 86,0
- Geschlecht
- F
- Eingang
- 07.11.2022
- Impfdatum
- 11.11.2021
- Beginn
- 31.10.2022
- Tage bis Beginn
- 354,0
- Dosis
- 3
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Asthenia
COVID-19
Cough
Failure to thrive
SARS-CoV-2 test positive
Symptomtext
Patient received Pfizer COVID vaccine on 2/4/21 (lot # EL9264), 2/25/21 (lot # EL9266), and 11/11/21 (lot # 33026BD). On 10/31/22, patient admitted to our inpatient facility (med/surg unit) with COVID-19 infection, failure to thrive (generalized weakness), and chronic cough. As of today (11/7/22), patient is still admitted in the med/surg unit.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Asthenia
- Hospital-Tage
- 7,0
- Labordaten
- COVID status positive 10/31/22.
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- ALF resident with history of CAD, HTN, HLD, MR, CKD, hx of CVA glaucoma, and hearing loss
- Andere Medikamente
- amlodipine, atorvastatin, aspirin, vitamin b12, lisinopril, polyethylene glycol, preservision areds
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 73,0
- Geschlecht
- F
- Eingang
- 08.09.2022
- Impfdatum
- 21.01.2021
- Beginn
- 19.08.2022
- Tage bis Beginn
- 575,0
- Dosis
- 3
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: ja
Arteriosclerosis coronary artery
Brain natriuretic peptide normal
COVID-19
Cardiac stress test abnormal
Catheterisation cardiac abnormal
Chest discomfort
Myocardial ischaemia
SARS-CoV-2 test positive
Troponin normal
Symptomtext
75y.o. female with a PMHx significant for asthma, breast ca, hypothyroid, HLD, and as below. Pt presents with c/o worsening chest pressure over the past week. Pt underwent stress test on 8/19 which showed myocardial ischemia to the distal anterior wall and apical wall segment. Pt has cardiac cath planned for 9/19/22. Pt states since chest pressure not improving she decided to present to ED. Pt states upon ED arrival chest pressure improved after receiving SL nitro x3. Upon ED evaluation troponin negative x1, BNP 48. Pt admitted for cardiology evaluation and underwent cardiac cath 8/21 with Dr showed very mild coronary atherosclerosis. Pulmonary consulted per cardio rec, increased symbicort doses and continue albuterol as needed. Referral given for pulmonary rehab. Discussed with nursing staff. Patient is cleared and discharged in a stable condition.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Arteriosclerosis coronary artery
- Hospital-Tage
- 4,0
- Labordaten
- 8/19 SARS-CoV-2 (COVID-19) by Nucleic Acid Amplification, POC --detected
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MD
- Alter
- 52,0
- Geschlecht
- F
- Eingang
- 27.08.2022
- Impfdatum
- 01.11.2021
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 3
- Route/Site
- - / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
Drug ineffective
Symptomtext
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient. A 53-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 25Mar2021 at 10:00 as dose 1, single (Lot number: ER2613), in left arm, on 19Aug2021 at 16:15 as dose 2, single (Lot number: EW0158), in left arm and on 01Nov2021 at 13:30 as dose 3 (booster), single (Lot number: 33026BD) at the age of 52 years, in left arm for covid-19 immunisation; coviD-19 vaccine mrna (mrna 1273) (MODERNA COVID-19 VACCINE), on 01Apr2022 at 12:00 as dose 4 (booster), single (Batch/Lot number: unknown), in left arm for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. Past drug history included: Known allergies: ceftin, reaction(s): "Drug Allergy". The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 2022, outcome "unknown" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of drug ineffective, covid-19. Clinical information: The patient had not taken any other medication in 2 weeks. Patient was treated with Paxlovid from 28Apr2022 to 01May2022.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 83,0
- Geschlecht
- F
- Eingang
- 25.07.2022
- Impfdatum
- 01.12.2021
- Beginn
- 18.07.2022
- Tage bis Beginn
- 229,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19
SARS-CoV-2 test positive
Vaccine breakthrough infection
Symptomtext
Confirmed Breakthrough Case: COVID-19 (Janssen) 1- 03/18/2021- Janssen- Lot 1802068 COVID-19 (Pfizer) 2- 12/01/2021- Pfizer- Lot 33026BD.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19
- Hospital-Tage
- -
- Labordaten
- Positive Covid lab test - 7/18/2022.
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 39,0
- Geschlecht
- F
- Eingang
- 17.06.2022
- Impfdatum
- 23.11.2021
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 3
- Route/Site
- - / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
SARS-CoV-2 test
Vaccination failure
Symptomtext
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient. A 40-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 06Apr2021 at 11:15 as dose 1, single (Lot number: ER8737), in left arm, on 27Apr2021 at 13:15 as dose 2, single (Lot number: ER8735), in left arm and on 23Nov2021 at 14:15 as dose 3 (booster), single (Lot number: 33026BD) at the age of 39 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Hypertension" (unspecified if ongoing); "Obesity" (unspecified if ongoing); "General Anxiety Disorder" (unspecified if ongoing); "Major Depressive Disorder" (unspecified if ongoing); "Hypothyroidism" (unspecified if ongoing); "Chronic Bronchitis" (unspecified if ongoing). Concomitant medication(s) included: VALSARTAN 40mg, start date: Jan2021; VITAMIN D3 125mcg, start date: Apr2019; VITAMIN B12 1000mcg [CYANOCOBALAMIN], start date: Apr2019; BUPROPION HCL 300mg, start date: Mar2021; FOLIC ACID 1mg, start date: Jan2020; CETIRIZINE HYDROCHLORIDE 10mg, start date: Apr2019; FERROUS SULFATE 325mg, start date: Apr2019. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (07Jun2022) negative; (10Jun2022) positive. Therapeutic measures were taken as a result of vaccination failure, covid-19. Clinical course: Patient received other medications in two weeks. Patient received paxlovid from 02Jun2022 to 06Jun2022 (lot number: FY565719) for COVID-19 treatment. Adverse event reported as, after completing the full course of treatment on monday, 06Jun, and testing negative on an at-home lateral flow test on tuesday, 07Jun, she developed a sore throat and cough that worsened throughout the afternoon and evening of thursday, 09Jun. She woke up with a persistent sore throat, cough, and congestion on friday, 10Jun, performed another at-home lateral flow test that shows she was positive for Covid-19. Adverse events were recovering and no treatment received for adverse events. Patient had no known allergies. Product investigation summary conclusion on 13Jun2022 included for LOT#33026BD, the complaint for a lack of effect in a vial of Pfizer BioNTech COVID-19 vaccine was investigated. The investigation included reviewing incoming quality and manufacturing batch records, deviation investigations, an analysis of the complaint history for the reported lot and product type and final release assay testing. This product was received as preformulated bulk, and was manufactured, labeled, and packaged by Pfizer (withheld). The final scope was determined to be lot 33026BD. No quality issues were identified during the investigation. There was no impact on product quality. An was not issued for the complaint. No regulatory notifications were held because of this complaint. The complaint condition of lack of effect was not confirmed, therefore the root cause cannot be attributed to the manufacture or vendor processes as incoming quality component verification of the certificate of compliance with no significant investigations that would have affected product quality and the results of all analytical tests performed at the time of lot release confirmed that the batch met all release specifications. No corrective or preventative actions are required as the complaint condition was not determined to be manufacture or vendor related and there are quality systems in place to detect defects prior to any lot being released to the market. PR ID of Previously Completed Inv: 6040511, PR Link (Previously Investigated CR): 6825854. Conclusion of previously completed investigation for LOT#ER8735: The complaint for lack of effect of the Pfizer BioNTech COVID-19 vaccine lot ER8735 was investigated. The investigation included a review of manufacturing and packaging batch records, deviation investigations, and an analysis of complaint history for the reported lot. Analytical release test results were also reviewed. The final scope included the reported finished goods lot ER8735, fill lot EP8687, and the formulated drug product lot EP8574. A complaint sample was not returned, and photographs were not received. No related quality issues were identified during the investigation. There was no impact to product quality. No root cause or corrective/prevent ative actions were identified as the complaint was not confirmed. All release testing performed prior to the release of the reported batch was within specifications. PR ID of Previously Completed Inv: 6040511, PR Link (Previously Investigated CR): 6025183. Conclusion of previously completed investigation for LOT#ER8737: The complaint for lack of effect of the Pfizer BioNTech COVID-19 vaccine lot ER8737 was investigated. The investigation included a review of manufacturing and packaging batch records, deviation investigations, and an analysis of complaint history for the reported lot. The final scope included the reported finished goods lot ER8737, fill lot EW3426, and the formulated drug product lot EP8586. A complaint sample was not returned, and photographs were not received. No related quality issues were identified during the investigation. There was no impact to product quality. No root cause or corrective/prevent ative actions were identified as the complaint was not confirmed. All release testing performed prior to the release of the reported batch was within specifications. PR ID of Previously Completed Inv: 5861480, PR Link (Previously Investigated CR): 5857105.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19
- Hospital-Tage
- -
- Labordaten
- Test Date: 20220607; Test Name: home lateral flow test; Test Result: Negative ; Test Date: 20220610; Test Name: home lateral flow test; Test Result: Positive
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Chronic bronchitis; Generalized anxiety disorder; Hypertension; Hypothyroidism; Major depressive disorder; Obesity
- Andere Medikamente
- VALSARTAN; VITAMIN D3; VITAMIN B12 [CYANOCOBALAMIN]; BUPROPION HCL; FOLIC ACID; CETIRIZINE HYDROCHLORIDE; FERROUS SULFATE
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 66,0
- Geschlecht
- M
- Eingang
- 02.06.2022
- Impfdatum
- 01.12.2021
- Beginn
- 30.05.2022
- Tage bis Beginn
- 180,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Asymptomatic COVID-19
Intracranial mass
SARS-CoV-2 test positive
Symptomtext
Patient admitted as inpatient on 5/30/22 due to a brain mass. Patient was tested for COVID-19 and was positive on 5/31/22 (asymptomatic) upon admission.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Asymptomatic COVID-19
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 65,0
- Geschlecht
- M
- Eingang
- 02.06.2022
- Impfdatum
- 17.11.2021
- Beginn
- 01.05.2022
- Tage bis Beginn
- 165,0
- Dosis
- 3
- Route/Site
- - / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Suspected COVID-19
Vaccination failure
Symptomtext
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 65-year-old male patient received BNT162b2 (BNT162B2), on 10Mar2021 as dose 1, single (Lot number: EN6202), in left arm, on 31Mar2021 as dose 2, single (Lot number: ER8732), in left arm and on 17Nov2021 as dose 3 (booster), single (Lot number: 33026BD) at the age of 65 years, in left arm for covid-19 immunization; carvedilol (CARVEDILOL), (Batch/Lot number: unknown) at 6.25 mg 2x/day for hypertension; losartan (LOSARTAN), (Batch/Lot number: unknown) at 50 mg 1x/day for hypertension and also reported as other medications/products within 2 weeks. The patient's relevant medical history included: "HTN" (unspecified if ongoing), notes: HTN; "High Cholesterol" (unspecified if ongoing); "Stent RCA", start date: Sep2011, stop date: Sep2011, notes: Stent RCA. Concomitant medication(s) included: ASPIRIN. The following information was reported: VACCINATION FAILURE (medically significant), SUSPECTED COVID-19 (medically significant) all with onset May2022, outcome "unknown" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of vaccination failure, suspected covid-19. Clinical course was reported as, The stopped all medicine for HTN (hypertension), Cholesterol and aspirin day 1 and proceeded on Paxlovid treatment as scheduled with no variation in dosage or application. On day 3 started HTN (hypertension) medicine only (Carvedilol 6.25mg BID and Losartan 50mg once daily), headaches started within a couple of hours and persisted until I took 1300 mg Acetaminophen. Day 4, same results/same treatment. The patient had headaches, so, he thought this was odd. There was no change in routine, and he was well hydrated. Slight diarrhea but not severe. The nasal and mouth taste is awful but the treatment worked. The patient started to feel better on Day 3 and improved measurably over the remaining 2 days of treatment. No follow-up attempts are possible. No further information is expected.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Suspected COVID-19
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Stent placement (Stent RCA)
- Vorgeschichte
- Medical History/Concurrent Conditions: High cholesterol; Hypertension (HTN)
- Andere Medikamente
- aspirin; CARVEDILOL; LOSARTAN
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 67,0
- Geschlecht
- M
- Eingang
- 10.05.2022
- Impfdatum
- 15.11.2021
- Beginn
- 02.05.2022
- Tage bis Beginn
- 168,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Anaemia
COVID-19
Faeces discoloured
Gastrointestinal haemorrhage
Respiratory symptom
SARS-CoV-2 test positive
Symptomtext
Pt admitted earlier this morning to several days of maroon-colored stools and acute anemia likely due to GI bleed. Please notes for additional details. Has not noted any additional RN colored stools or other GI bleeding this morning. Denies any abdominal pain, heartburn, chest pain, shortness of breath, dizziness or lightheadedness, or other new symptoms this morning. Noted to have positive COVID test ear. Reports positive home COVID test 3 weeks ago and full resolution of URI symptoms that he was having at that time. No current URI symptoms
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Anaemia
- Hospital-Tage
- 3,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- 64,0
- Geschlecht
- F
- Eingang
- 04.05.2022
- Impfdatum
- 22.11.2021
- Beginn
- 10.01.2022
- Tage bis Beginn
- 49,0
- Dosis
- 3
- Route/Site
- - / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Alopecia
Symptomtext
after booster (3rd shot) my hair started falling out. The shedding hair is beyond excessive. Literally handfulls of hair lost daily.; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 64-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 22Nov2021 at 18:15 as dose 3 (booster), single (Lot number: 33026BD) at the age of 64 years, in right arm for covid-19 immunisation. The patient's relevant medical history included: "Multiple sclerosis" (unspecified if ongoing); "Allergy of pepper" (unspecified if ongoing). There were no concomitant medications. Vaccination history included: BNT162b2 (Dose 2, Dose brand unknown: False, Dose lot number: EW0171, Dose administration time: 03:45PM, Dose vaccine location: Right arm), administration date: 28Apr2021, when the patient was 64-year-old, for COVID-19 immunization; BNT162b2 (Dose 1, Dose brand unknown: False, Dose lot number: EP7533, Dose administration time: 04:00PM, Prev dose vaccine location: Right arm), administration date: 31Mar2021, when the patient was 64-year-old, for COVID-19 immunization. The following information was reported: ALOPECIA (non-serious) with onset 10Jan2022, outcome "not recovered", described as "after booster (3rd shot) my hair started falling out. The shedding hair is beyond excessive. Literally handfulls of hair lost daily.". Therapeutic measures were not taken as a result of alopecia. Additional information: The patient had not received any other vaccine within 4 weeks. Patient had not been diagnosed with COVID-19 prior to vaccination and had not been tested since the vaccination.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Alopecia
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Multiple sclerosis; Spice allergy
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 64,0
- Geschlecht
- F
- Eingang
- 03.05.2022
- Impfdatum
- 15.11.2021
- Beginn
- 14.04.2022
- Tage bis Beginn
- 150,0
- Dosis
- 3
- Route/Site
- - / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
SARS-CoV-2 test
Vaccination failure
Symptomtext
developing COVID symptoms; developing COVID symptoms; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 64-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 12Mar2021 as dose 1, single (Lot number: EN6208), in left arm, on 06Apr2021 as dose 2, single (Lot number: EP6955), in left arm and on 15Nov2021 as dose 3 (booster), single (Lot number: 33026BD) at the age of 64 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "High cholesterol" (unspecified if ongoing). Concomitant medication(s) included: ATORVASTATIN, start date: 01Feb2017, stop date: 13Apr2022; ESCITALOPRAM, start date: 30Apr2020. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 14Apr2022, outcome "unknown" and all described as "developing COVID symptoms". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) Positive, notes: rapid at-home test, which was positive again. I still have symptoms 4 days later, and continue to test positive; (14Apr2022) Positive; (19Apr2022) Negative, notes: at-home rapid test; (20Apr2022) Positive; (23Apr2022) Positive. Therapeutic measures were taken as a result of covid-19. Clinical course: Patient had no known allergies. Patient had received other medications within two weeks. Adverse event- Started taking Paxlovid after developing COVID symptoms of a scratchy throat and cough, and after testing positive. Took the pills as prescribed twice a day, for the full five days of the course. Felt better within 3 days of taking Paxlovid, and tested negative on an at-home rapid test on days 5 and 6 after first testing positive and starting Paxlovid. 4 days later (day 9 after testing positive and starting Paxlovid), patient started developing a sore throat, cough, and congestion again, and took another rapid at home test, which was positive again. Patient still have symptoms 4 days later, and continue to test positive. No follow-up attempts are possible. No further information is expected.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19
- Hospital-Tage
- -
- Labordaten
- Test Name: COVID; Test Result: Positive ; Comments: rapid at-home test, which was positive again. I still have symptoms 4 days later, and continue to test positive.; Test Date: 20220414; Test Name: COVID; Test Result: Positive ; Test Date: 20220419; Test Name: COVID; Test Result: Negative ; Comments: at-home rapid test; Test Date: 20220420; Test Name: COVID; Test Result: Positive ; Test Date: 20220423; Test Name: COVID; Test Result: Positive
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: High cholesterol
- Andere Medikamente
- ATORVASTATIN; ESCITALOPRAM
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- VA
- Alter
- 84,0
- Geschlecht
- M
- Eingang
- 21.04.2022
- Impfdatum
- 27.10.2021
- Beginn
- 28.10.2021
- Tage bis Beginn
- 1,0
- Dosis
- 3
- Route/Site
- - / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Abdominal discomfort
Chest discomfort
Limb discomfort
Symptomtext
Felt severe pressure on chest, abdomen, & legs; Felt severe pressure on chest, abdomen, & legs; Felt severe pressure on chest, abdomen, & legs; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. An 84-year-old male patient received BNT162b2 (BNT162B2), on 27Oct2021 at 13:00 as dose 3 (booster), single (Lot number: 33026BD) at the age of 84 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "kidney disease" (unspecified if ongoing); "Multi cystic liver" (unspecified if ongoing). Concomitant medication(s) included: RAMIPRIL; ATENOLOL; ATORVASTATIN. Vaccination history included: BNT162b2 (Dose Number: 2, Batch/Lot No: EN5318, Location of injection: Arm Left), administration date: 03Feb2021, for COVID-19 immunization; BNT162b2 (Dose Number: 1, Batch/Lot No: EL8982, Location of injection: Arm Left, Vaccine Administration Time: 01:00 PM), administration date: 13Jan2021, for COVID-19 immunization. The following information was reported: CHEST DISCOMFORT (non-serious), ABDOMINAL DISCOMFORT (non-serious), LIMB DISCOMFORT (non-serious) all with onset 28Oct2021 at 04:00, outcome "recovered" and all described as "Felt severe pressure on chest, abdomen, & legs". Therapeutic measures were not taken as a result of chest discomfort, abdominal discomfort, limb discomfort. Additional information: The patient had not diagnosed with covid prior vaccination. And post vaccination, patient had not tested with covid. No known allergies reported for the patient. No follow-up attempts are possible. No further information is expected.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Abdominal discomfort
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Kidney disorder; Polycystic liver disease
- Andere Medikamente
- RAMIPRIL; ATENOLOL; ATORVASTATIN
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 15,0
- Geschlecht
- F
- Eingang
- 24.03.2022
- Impfdatum
- 15.12.2021
- Beginn
- 15.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
TEMPERATURE EXCURSION. vaccine (covid) was stored in the freezer longer than manufacture recommendations. Patient did not have any adverse reactions.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 16,0
- Geschlecht
- F
- Eingang
- 24.03.2022
- Impfdatum
- 15.12.2021
- Beginn
- 15.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
TEMPERATURE EXCURSION. vaccine (covid) was stored in the freezer longer than manufacture recommendations. Patient did not have any adverse reactions.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 12,0
- Geschlecht
- M
- Eingang
- 24.03.2022
- Impfdatum
- 15.12.2021
- Beginn
- 15.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
TEMPERATURE EXCURSION. vaccine (covid) was stored in the freezer longer than manufacture recommendations. Patient did not have any adverse reactions.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 19,0
- Geschlecht
- M
- Eingang
- 23.03.2022
- Impfdatum
- 15.12.2021
- Beginn
- 15.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
TEMPERATURE EXCURSION. vaccine (Covid) was stored in the freezer longer than manufacture recommendations. Patient did not have any adverse reactions.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 37,0
- Geschlecht
- F
- Eingang
- 09.03.2022
- Impfdatum
- 03.11.2021
- Beginn
- 01.12.2021
- Tage bis Beginn
- 28,0
- Dosis
- 3
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Alopecia
Alopecia areata
Symptomtext
Alopecia Areata along with major hair fall
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Alopecia
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 63,0
- Geschlecht
- F
- Eingang
- 05.03.2022
- Impfdatum
- 01.11.2021
- Beginn
- 01.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- - / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Alopecia
Inappropriate schedule of product administration
Symptomtext
Dose 1 given 25Aug2021; Dose 2 01Nov2021; Severe hair loss; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 63 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 01Nov2021 16:00 (Lot number: 33026BD) at the age of 63 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Chronic pain" (unspecified if ongoing), notes: Chronic pain due to botched surgery; "botched surgery" (unspecified if ongoing), notes: Chronic pain due to botched surgery; "allergies: sulfa drugs" (unspecified if ongoing), notes: known_allergies: Pain meds, sulfur drugs. Concomitant medication(s) included: FLU, administration date Oct2021; XOLAIR; METHADONE; PAMELOR; ATIVAN. Vaccination history included: Bnt162b2 (Dose Number: 1, Lot No: FC3138, Location of injection: Arm Left, Vaccine Administration Time: 16:00), administration date: 25Aug2021, when the patient was 63 years old, for Covid-19 Immunization. The following information was reported: INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (non-serious) with onset 01Nov2021, outcome "unknown", described as "Dose 1 given 25Aug2021; Dose 2 01Nov2021"; ALOPECIA (non-serious) with onset Nov2021, outcome "not recovered", described as "Severe hair loss". Therapeutic measures were not taken as a result of alopecia. Additional information: Prior to vaccination patient was not diagnosed with COVID-19. Since the vaccination patient had not tested for COVID-19. No follow-up attempts are possible. No further information is expected.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Alopecia
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Chronic pain (Chronic pain due to botched surgery); Plastic surgery (Chronic pain due to botched surgery); Sulfonamide allergy (known_allergies: Pain meds, sulfur drugs)
- Andere Medikamente
- XOLAIR; METHADONE; PAMELOR; ATIVAN
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 39,0
- Geschlecht
- F
- Eingang
- 28.02.2022
- Impfdatum
- 29.11.2021
- Beginn
- 05.12.2021
- Tage bis Beginn
- 6,0
- Dosis
- 3
- Route/Site
- SYR / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: ja
ER: unbekannt
Erholt: nein
Acoustic stimulation tests
Tinnitus
Symptomtext
Tinnitus in left ear, constant since December 5th 2021, several days after my booster.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acoustic stimulation tests
- Hospital-Tage
- -
- Labordaten
- Hearing test on 2/23/2022. Follow up ear examination and consultation on 2/28/2022.
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 50,0
- Geschlecht
- M
- Eingang
- 17.02.2022
- Impfdatum
- 15.12.2021
- Beginn
- 09.02.2022
- Tage bis Beginn
- 56,0
- Dosis
- 2
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19
Vaccine breakthrough infection
Symptomtext
Breakthrough covid infection
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 32,0
- Geschlecht
- F
- Eingang
- 16.02.2022
- Impfdatum
- 11.11.2021
- Beginn
- 12.11.2021
- Tage bis Beginn
- 1,0
- Dosis
- 2
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Abortion spontaneous
Exposure during pregnancy
Symptomtext
Miscarried, Traumatic event. 6 Weeks Pregnant with Estimated date of delivery: 07/07/2022.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Abortion spontaneous
- Hospital-Tage
- -
- Labordaten
- Miscarried.
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- N/A
- Andere Medikamente
- Lamictal, Cymbalta
- Allergien
- N/A
- Vorherige Impfungen
- -
- Staat
- OR
- Alter
- 11,0
- Geschlecht
- F
- Eingang
- 09.02.2022
- Impfdatum
- 10.01.2022
- Beginn
- 10.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Incorrect dose administered
No adverse event
Symptomtext
There was no adverse reaction reported by the client. There were given an adult dose of the covid vaccine, instead of the pediatric covid vaccine.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- n/a
- Allergien
- None.
- Vorherige Impfungen
- -
- Staat
- AZ
- Alter
- 4,0
- Geschlecht
- M
- Eingang
- 27.01.2022
- Impfdatum
- 16.11.2021
- Beginn
- 16.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
No adverse event
Product administered to patient of inappropriate age
Symptomtext
patient was not of age to receive vaccine at the time of vaccination; mom denies any side effects following vaccination or at the time of vaccination.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- n/a
- Vorgeschichte
- n/a
- Andere Medikamente
- n/a
- Allergien
- KNDA
- Vorherige Impfungen
- -
- Staat
- MN
- Alter
- 14,0
- Geschlecht
- F
- Eingang
- 25.01.2022
- Impfdatum
- 16.01.2022
- Beginn
- 16.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
Vaccine administered after stored at freezer temperature for too long. Patient advised and may get revaccinated.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MN
- Alter
- 13,0
- Geschlecht
- F
- Eingang
- 25.01.2022
- Impfdatum
- 16.01.2022
- Beginn
- 16.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
Vaccine administered after stored at freezer temperature for too long. Patient advised and may get revaccinated.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MN
- Alter
- 16,0
- Geschlecht
- M
- Eingang
- 25.01.2022
- Impfdatum
- 17.01.2022
- Beginn
- 17.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
Vaccine administered after stored at freezer temperature for too long. Patient advised and may get revaccinated.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MN
- Alter
- 13,0
- Geschlecht
- M
- Eingang
- 25.01.2022
- Impfdatum
- 17.01.2022
- Beginn
- 17.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
Vaccine administered after stored at freezer temperature for too long. Patient advised and may get revaccinated.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MN
- Alter
- 15,0
- Geschlecht
- F
- Eingang
- 25.01.2022
- Impfdatum
- 17.01.2022
- Beginn
- 17.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
Vaccine administered after stored at freezer temperature for too long. Patient advised and may get revaccinated.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MN
- Alter
- 33,0
- Geschlecht
- M
- Eingang
- 25.01.2022
- Impfdatum
- 17.01.2022
- Beginn
- 17.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
Vaccine administered after stored at freezer temperature for too long. Patient advised and may get revaccinated.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MN
- Alter
- 55,0
- Geschlecht
- F
- Eingang
- 24.01.2022
- Impfdatum
- 17.01.2022
- Beginn
- 17.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
Vaccine administered after stored at freezer temperature for too long. Patient advised and may get revaccinated.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MN
- Alter
- 25,0
- Geschlecht
- F
- Eingang
- 24.01.2022
- Impfdatum
- 18.01.2022
- Beginn
- 18.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
Product storage error
Symptomtext
Vaccine administered after stored at freezer temperature for too long. Patient advised and may get revaccinated.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MN
- Alter
- 28,0
- Geschlecht
- M
- Eingang
- 24.01.2022
- Impfdatum
- 18.01.2022
- Beginn
- 18.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
Vaccine administered after stored at freezer temperature for too long. Patient advised and may get revaccinated.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MN
- Alter
- 21,0
- Geschlecht
- M
- Eingang
- 24.01.2022
- Impfdatum
- 19.01.2022
- Beginn
- 19.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
Vaccine administered after stored at freezer temperature for too long. Patient advised and may get revaccinated.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MN
- Alter
- 90,0
- Geschlecht
- F
- Eingang
- 24.01.2022
- Impfdatum
- 20.01.2022
- Beginn
- 20.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
Vaccine administered after stored at freezer temperature for too long. Patient advised and may get revaccinated.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MN
- Alter
- 40,0
- Geschlecht
- F
- Eingang
- 24.01.2022
- Impfdatum
- 15.01.2022
- Beginn
- 15.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
VACCINE ADMINISTERED WAS STORED AT FREEZER TEMPERATURE FOR TOO LONG
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 47,0
- Geschlecht
- F
- Eingang
- 13.01.2022
- Impfdatum
- 07.12.2021
- Beginn
- 09.01.2022
- Tage bis Beginn
- 33,0
- Dosis
- UNK
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: ja
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Unevaluable event
Symptomtext
PT HAD MULTIPLE PE AND WAS HOSPITALIZED
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Unevaluable event
- Hospital-Tage
- 3,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- PT WAS ALSO TAKING GENERIC LORYNA AND FAMOTIDINE 20 MG BID
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 39,0
- Geschlecht
- F
- Eingang
- 06.01.2022
- Impfdatum
- 27.12.2021
- Beginn
- 04.01.2022
- Tage bis Beginn
- 8,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19
Chest X-ray abnormal
Febrile neutropenia
Lung infiltration
SARS-CoV-2 test positive
Sepsis
Symptomtext
Patient received Moderna COVID vaccine on 4/2/21 (lot 026B21A) and 4/30/21 (lot 017C21A), and Pfizer COVID vaccine on 12/27/21 (lot 33026BD). On 1/4/22, patient was tested positive for COVID and admitted to our facility for neutropenic fever (after recent administration of R-CHOP for diffuse large B-cell lymphoma), sepsis, and COVID-19 infection. Patient has infiltrates on her chest x-ray though it may be bacterial pneumonia in the setting of neutropenia. As of today (1/5/22), patient is still admitted in our med/surg unit.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19
- Hospital-Tage
- 1,0
- Labordaten
- COVID status positive 1/4/22.
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- recently diagnosed diffuse large B cell lymphoma who completed first round of R-CHOP completed on 12/28 and 12/29 and acute kidney injury secondary to compression of her ureters resulting in placement of ureteral stents
- Andere Medikamente
- acetaminophen, acyclovir, allopurinol, levonorgestrel IUD, methocarbamol, metoclopramide, prochlorperazine
- Allergien
- ondansetron, naproxen, oxycodone, hydrocodone, morphine
- Vorherige Impfungen
- -
- Staat
- ME
- Alter
- 15,0
- Geschlecht
- M
- Eingang
- 20.12.2021
- Impfdatum
- 15.12.2021
- Beginn
- 15.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Extra dose administered
Symptomtext
Patient not yet at age for booster of Covid
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- Fluoxetine 30mg
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 11,0
- Geschlecht
- M
- Eingang
- 17.12.2021
- Impfdatum
- 16.12.2021
- Beginn
- 16.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Incorrect dose administered
Symptomtext
Adult formulation of Pfizer given. 11 years old, should have received the Pfizer 5-11 formulation
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- ME
- Alter
- 12,0
- Geschlecht
- F
- Eingang
- 14.12.2021
- Impfdatum
- 13.12.2021
- Beginn
- 13.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Immunisation
Symptomtext
Patient COVID vaccine dose administered on 12/13/21 past the expiration/beyond-use date. Per manufacturer patient is to repeat the dose immediately. Patient is notified. They will consider repeat dose.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Autism spectrum disorder requiring support (level 1)-with language and intellectual impairment. Delayed milestones Global developmental delay Hypotonia Large pupils
- Andere Medikamente
- -
- Allergien
- Dairy products, Gluten Flour
- Vorherige Impfungen
- -
- Staat
- ME
- Alter
- 14,0
- Geschlecht
- M
- Eingang
- 14.12.2021
- Impfdatum
- 10.12.2021
- Beginn
- 10.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product administered to patient of inappropriate age
Symptomtext
Patient given 3rd dose of Pfizer vaccine and did not meet age guidelines. No adverse reaction known.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Aplastic Anemia
- Andere Medikamente
- none
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- ME
- Alter
- 22,0
- Geschlecht
- M
- Eingang
- 14.12.2021
- Impfdatum
- 13.12.2021
- Beginn
- 13.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Immunisation
No adverse event
Symptomtext
Patient COVID vaccine 12/13/21 past the expiration/beyond-use date as of 12/10/21 was inadvertently mixed and given and administered to patient. Call was made to manufacture and was told to repeat dose immediately. Patient had no symptoms at the time of vaccine administration.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- abnormal CT scan, kidney, color blindness, generalized anxiety disorder, intermittent asthma
- Andere Medikamente
- Patient COVID vaccine dose administered on 12/13/21 past the beyond-use date.
- Allergien
- peanuts, amoxicillin, animal dander, dust mite, grass pollen, singular, tree pollen, prednisone(nausea and vomiting)
- Vorherige Impfungen
- -
- Staat
- NM
- Alter
- 16,0
- Geschlecht
- M
- Eingang
- 07.12.2021
- Impfdatum
- 07.12.2021
- Beginn
- 07.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product administered to patient of inappropriate age
Symptomtext
Administered Booster Covid-19 vaccine when not indicated by patient age, 16 years old
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- unknown
- Aktuelle Erkrankungen
- unknown
- Vorgeschichte
- unknown
- Andere Medikamente
- unknown
- Allergien
- unknown
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 34,0
- Geschlecht
- M
- Eingang
- 07.12.2021
- Impfdatum
- 06.12.2021
- Beginn
- 06.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Inappropriate schedule of product administration
Symptomtext
Patient was given the second dose too early. Was given at day 13 instead of day 21.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- N/A
- Andere Medikamente
- N/A
- Allergien
- NKA
- Vorherige Impfungen
- -
- Staat
- OR
- Alter
- 13,0
- Geschlecht
- F
- Eingang
- 06.12.2021
- Impfdatum
- 17.11.2021
- Beginn
- 17.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Extra dose administered
No adverse event
Product administered to patient of inappropriate age
Symptomtext
No adverse events noted. 13 year old inadvertently administered a booster dose of Pfizer COVID-19 vaccine, which is only approved for 18+.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OR
- Alter
- 15,0
- Geschlecht
- M
- Eingang
- 06.12.2021
- Impfdatum
- 17.11.2021
- Beginn
- 17.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Incorrect product formulation administered
No adverse event
Symptomtext
No adverse events noted. Pediatric formulation of COVID-19 vaccine inadvertently administered to 15 year old. In consultation with clinical director, a subsequent dose of the age appropriate formulation was administered 20 minutes later.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect product formulation administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 60,0
- Geschlecht
- F
- Eingang
- 06.12.2021
- Impfdatum
- 03.12.2021
- Beginn
- 06.12.2021
- Tage bis Beginn
- 3,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
Vaccine was expired on 12/2 but administered on 12/3. Writer called Pfizer and was told no adverse outcome expected and dose still valid due to stability testing completed.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 17,0
- Geschlecht
- F
- Eingang
- 05.12.2021
- Impfdatum
- 04.12.2021
- Beginn
- 04.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Extra dose administered
No adverse event
Product administered to patient of inappropriate age
Symptomtext
Erroneous administration of booster dose to patient under 18 years old (current booster recommendations are for 18 years and old). no patient harm observed
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 50,0
- Geschlecht
- M
- Eingang
- 02.12.2021
- Impfdatum
- 02.12.2021
- Beginn
- 02.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Inappropriate schedule of product administration
No adverse event
Symptomtext
Patient was given COVID booster (3rd dose) too early by a staff member here at our office. See timeline below... 09/29/2021- Pfizer COVID Vaccine 11/02/2021- Pfizer COVID Vaccine 12/02/2021 - Pfizer COVID Vaccine Patient was monitored for 30 minutes after injection, and experienced no side effects. We will continue to call and monitor patient for the next few days.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- 11/11/21 - Seen by PCP for urinary symptoms & hemorrhoids - urine was negative for infection. 12/02/21 - No issues today.
- Vorgeschichte
- Low Back Pain IBS
- Andere Medikamente
- Methocarbamol PRN Paxil Atorvastatin Ibuprofen PRN Tramadol PRN
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- MN
- Alter
- 27,0
- Geschlecht
- F
- Eingang
- 01.12.2021
- Impfdatum
- 27.11.2021
- Beginn
- 28.11.2021
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Mydriasis
Ocular discomfort
Ocular hyperaemia
Symptomtext
My eyes have been blood shot the last 5 days with dilated pupils and pressure behind my eyes. It is starting to fade but the pressure is still there and my eyes are more of a pink now. I did not go into the Clinic but I did message my Doctor.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Mydriasis
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- Histamine intolerance and mold toxicity
- Vorgeschichte
- Hypothyroidism
- Andere Medikamente
- Levothyroxine, liothyronine, mulit Vitamin, magnesium
- Allergien
- Histamine Intolerance
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 17,0
- Geschlecht
- M
- Eingang
- 30.11.2021
- Impfdatum
- 24.11.2021
- Beginn
- 24.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
No adverse event
Product administered to patient of inappropriate age
Symptomtext
NO ADVERSE EVENTS, BUT PATIENT WAS NOT ELIGIBLE ACCORDING TO HIS AGE PER CURRENT CDC GUIDELINES
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MO
- Alter
- 40,0
- Geschlecht
- F
- Eingang
- 29.11.2021
- Impfdatum
- 01.11.2021
- Beginn
- 29.11.2021
- Tage bis Beginn
- 28,0
- Dosis
- 1
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Polymenorrhoea
Symptomtext
Started menstrual cycle 2 weeks early
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Polymenorrhoea
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- POP birth control Multivitamins
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 40,0
- Geschlecht
- F
- Eingang
- 26.11.2021
- Impfdatum
- 26.11.2021
- Beginn
- 26.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Inappropriate schedule of product administration
No adverse event
Symptomtext
No symptoms to date. Booster dose was given sooner than 6 months after second dose. Patient did not show any signs of reaction so far, just reporting that booster was given earlier than 6 months after second dose.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 17,0
- Geschlecht
- M
- Eingang
- 23.11.2021
- Impfdatum
- 23.11.2021
- Beginn
- 23.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product administered to patient of inappropriate age
Symptomtext
patient received a 3rd dose which is not currently approved for less than 18 years
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 39,0
- Geschlecht
- M
- Eingang
- 21.11.2021
- Impfdatum
- 21.11.2021
- Beginn
- 21.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Interchange of vaccine products
Symptomtext
Patient's first dose was Moderna on 10/24/2021, patient received their second dose today with Pfizer. Patient showed me their vaccine card on their phone since they didn't have it in person, the card showed Pfizer, and gave the patient Pfizer. But when we processed it through insurance, we saw that he got Moderna the first time. We are not sure what happened but we think patient might have accidentally shown their spouse's card. When giving the patient the vaccination, confirmed with him that we were doing Pfizer 2nd dose. Tried to call patient 4 times but patient did not pick up.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Interchange of vaccine products
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 8,0
- Geschlecht
- F
- Eingang
- 18.11.2021
- Impfdatum
- 17.11.2021
- Beginn
- 17.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Incorrect dose administered
Symptomtext
Client received adult Pfizer dose (30mcg) instead of Pediatric Pfizer dose (10mcg).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect dose administered
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- n/a
- Vorgeschichte
- n/a
- Andere Medikamente
- n/a
- Allergien
- n/a
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 23,0
- Geschlecht
- F
- Eingang
- 15.11.2021
- Impfdatum
- 13.11.2021
- Beginn
- 13.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Extra dose administered
No adverse event
Symptomtext
Patient was vaccinated with a booster dose in left arm by pharmacy technician. Then received another COVID 19 Booster dose in the same arm 4 minutes later. Patient left and came back to the pharmacy 10 minutes later to inform the pharmacy team that she had mistakenly received 2 booster doses. Patient didn't report any side effects and felt normal. Patient was informed to call pharmacy if any side effects or issues were to occur.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- No illnesses
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- No allergies
- Vorherige Impfungen
- -
- Staat
- MO
- Alter
- 11,0
- Geschlecht
- F
- Eingang
- 15.11.2021
- Impfdatum
- 14.11.2021
- Beginn
- 15.11.2021
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Incorrect dose administered
Product preparation issue
Symptomtext
patient was given the incorrect dose. the 12+ formulation was used and mixed using 1.3ml diluent and 0.2ml dose was given to the patient. Patient received a higher dose than she should have.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 90,0
- Geschlecht
- F
- Eingang
- 14.11.2021
- Impfdatum
- 14.11.2021
- Beginn
- 14.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Abnormal behaviour
Aggression
Gait inability
Symptomtext
15 MINUTES AFTER INJECTION 90 YEAR OLD FEMALE WITH PREVIOUS HISTORY OF DEMENTIA/PSYCOSIS SYMTOMS SAID SHE COULDN'T WALK TO CAR AND STARTED TRYING TO SPIT. WHEN PHARMACIST WENT TO PATIENT SHE TOLD HER TO LET HER ALONE-SHE WANTED TO GO HOME AND WAS KICKING AND TRYING TO HIT PHARMACIST. 911 WAS CALLED-AMBULANCE SHOWED UP AND PT CAREGIVER DECLINED CARE-JUST WANTED TO MAKE SURE PATIENT WAS NOT HAVING ALLERGIC REACTION TO VACCINEE AND PHARMACIST AND EMT SAID NO. IF HE HAD ANY CONCERNS HE CAN CALL BACK TO 911.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Abnormal behaviour
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- POSSIBLE DEMENTIA/PSYCHOSIS-90 YEAR OLD. HER SYMPTOMS AFTER VACCINATION HAVE OCCURRED PREVIOUS TO VACCINATION. PROBABLY THE STRESS OF GETTING THE VACCINNE UPSET HER ENOUG TO AGGITATE HER DEMENTIA.
- Andere Medikamente
- -
- Allergien
- NONE REPORTED
- Vorherige Impfungen
- -
- Staat
- SC
- Alter
- 12,0
- Geschlecht
- M
- Eingang
- 10.11.2021
- Impfdatum
- 10.11.2021
- Beginn
- 10.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Wrong product administered
Symptomtext
The vaccine was entered into the computer as a COVID 19 vaccine and the patient's mother filled out the VAERS for the COVID vaccine. When the pharmacist went to administer the vaccine, she asked the mother to come back with the child and she said that he did not want her back there with him. Patients name, date of birth, and vaccine were verified with the patient, the vaccine was administered, the patient left, then the mother came back saying her son was given the COVID vaccine when he was meant to receive a Tdap vaccine. No adverse event was reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Wrong product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -